This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)
C3_MESTOTHEL_SOFTTISSUE_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
2559 |
6. Filter based on genotype QC (FinnGen only) |
2559 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
Similar with less cases:
- Malignant neoplasm of mesothelium and soft tissue
- Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of other connective and soft tissue
- Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)
- Mesothelioma
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2559 | 1249 | 1310 |
| Unadjusted period prevalence (%) | 0.50 | 0.43 | 0.58 |
| Median age at first event (years) | 64.85 | 62.98 | 66.64 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1401
- Matched controls
- 14009
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
+∞
323.0
527
*
H02AB02
ATC
dexamethasone; systemic
124.1
323.0
455
54
A03FA01
ATC
metoclopramide; systemic, rectal
14.2
323.0
633
766
C45.0
ICD-10 Finland
Mesothelioma of pleura
+∞
323.0
299
*
JN4BD
NOMESCO Finland
Extensive body CT
20.4
284.0
447
314
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
2767.1
259.5
243
*
A04AA01
ATC
ondansetron; systemic, rectal
40.0
229.1
291
91
A04AA02
ATC
granisetron; systemic, transdermal
791.9
212.5
204
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
359.5
188.2
186
6
N02AA05
ATC
oxycodone; systemic
8.1
187.8
484
852
Z51.5
ICD-10 Finland
Palliative care
20.9
178.4
273
160
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
372.1
164.8
163
5
L03AA13
ATC
pegfilgrastim; parenteral
+∞
158.4
149
*
L03AA02
ATC
filgrastim; parenteral
296.3
158.0
158
6
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
16.0
148.0
250
187
WX302
NOMESCO Finland
Thoracal epidural anesthesy
24.3
147.8
214
103
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
138.9
131
*
JN4AD
NOMESCO Finland
Body CT examination
15.0
131.6
228
179
9050/3-C38.4
ICD-O-3
Mesothelioma, malignant of pleura, NOS
+∞
129.2
122
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
683.0
128.6
125
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
127.0
120
*
C49.29
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip other or unspecified tumor
+∞
121.6
115
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
28.4
120.3
166
66
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
10.9
119.2
242
264
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.6
111.7
845
4148
C49.20
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology
+∞
110.9
105
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
107.7
102
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
9.3
105.3
233
294
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
104.5
99
*
NFR30
NOMESCO Finland
Extended excision of soft tissue tumour of hip or thigh
540.9
103.0
101
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
102.3
97
*
XX3DW
NOMESCO Finland
Time consuming IT work
9.4
100.9
221
273
9052/3-C38.4
ICD-O-3
Epithelioid mesothelioma, malignant of pleura, NOS
+∞
100.2
95
*
WF002
NOMESCO Finland
Radical radiotherapy
114.5
98.4
106
10
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.7
97.3
550
2063
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
179.2
96.5
100
6
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
959.0
92.9
90
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
92.7
88
*
GAC01
NOMESCO Finland
Endoscopic biopsy of pleura
96.7
90.3
99
11
ZX090
NOMESCO Finland
Other technic of radiotherapy
924.8
89.8
87
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
242.9
89.6
91
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
89.5
85
*
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
17.6
88.5
142
89
B01AB10
ATC
tinzaparin; parenteral
8.9
87.7
198
255
A04AD12
ATC
aprepitant; systemic
+∞
87.4
83
*
WW500
NOMESCO Finland
Blood transfusion
14.9
82.8
142
105
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
19.2
82.4
128
73
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
176.2
80.0
83
5
WX408
NOMESCO Finland
General anesthesy, balanced
3.3
74.5
477
1890
B01AB05
ATC
enoxaparin; parenteral
3.1
74.1
548
2402
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
16.7
74.0
121
79
A04AA55
ATC
palonosetron, combinations; systemic
+∞
73.6
70
*
J94.8
ICD-10 Finland
Other specified pleural conditions
16.3
71.0
117
78
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
364.7
70.2
70
*
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
248.9
69.9
71
*
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
18.6
68.4
107
62
C48.89
ICD-10 Finland
Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor
+∞
67.2
64
*
C49.22
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including hip liposarcoma
+∞
67.2
64
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
678.9
66.5
65
*
JN4CD
NOMESCO Finland
Very extensive body CT
15.2
65.6
111
79
C49.2
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of lower limb, including hip
+∞
65.1
62
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
656.9
64.4
63
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
656.9
64.4
63
*
WZC30
NOMESCO Finland
Teaching
4.6
64.4
249
632
128
Kela drug reimbursment
Cancers of female genital organs
+∞
61.9
59
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
61.9
59
*
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
9.3
61.6
133
156
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.5
60.2
167
287
C48.02
ICD-10 Finland
Malignant tumor of the retroperitoneal space liposarcoma
+∞
59.8
57
*
WX402
NOMESCO Finland
General anaesthesia
3.8
58.8
283
874
C45.9
ICD-10 Finland
Mesothelioma, unspecified
+∞
58.7
56
*
JAL30
NOMESCO Finland
Omentectomy
44.5
58.5
72
17
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
56.6
54
*
C45.1
ICD-10 Finland
Mesothelioma of peritoneum
+∞
56.6
54
*
A79
ICPC
Malignancy NOS
292.7
55.6
56
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
55.6
53
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
558.8
54.9
54
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
9.4
54.3
116
133
ZX120
NOMESCO Finland
Intravenous
4.8
53.7
195
459
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
+∞
53.5
51
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
537.2
52.8
52
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
50.6
52.5
63
13
8850/3-C49.2
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
51.4
49
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
11.8
51.3
97
88
ZX070
NOMESCO Finland
Intensity modified radiotherapy
515.6
50.7
50
*
R4110
NOMESCO Finland
Physiotherapy
2.7
50.6
447
2086
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
137.5
50.1
53
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
6.2
50.0
142
250
8461/3-C48.2
ICD-O-3
High grade serous carcinoma of peritoneum, NOS
+∞
49.2
47
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
253.5
48.3
49
*
115
Kela drug reimbursment
Breast cancer
+∞
48.2
46
*
PJA12
NOMESCO Finland
Sentinel node biopsy
483.3
47.6
47
*
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
10.9
47.4
93
91
GAC00
NOMESCO Finland
Biopsy of pleura
51.9
46.1
55
11
TGA30
NOMESCO Finland
Thoracocentesis
29.4
46.0
62
22
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
12.5
46.0
84
71
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
56.0
45.8
54
10
TPH07
NOMESCO Finland
Cathetrisation of artery
3.8
45.4
211
622
116
Kela drug reimbursment
Prostate cancer
+∞
45.0
43
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
66.0
44.4
51
8
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
6.2
43.8
123
213
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
12.0
43.6
81
71
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
38.1
43.4
55
15
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
118.8
43.0
46
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
42.9
41
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
9.3
42.7
91
104
L02BG04
ATC
letrozole; oral
25.6
42.2
59
24
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.5
42.1
221
718
1BA04
NOMESCO Finland
NA
+∞
41.9
40
*
L01CA04
ATC
vinorelbine; systemic
+∞
41.9
40
*
NBR30
NOMESCO Finland
Extensive or radical excision of soft tissue tumour of shoulder or upper arm
419.2
41.3
41
*
GD1AD
NOMESCO Finland
Thorax CT examination
6.3
40.5
112
190
ZZA00
NOMESCO Finland
Split skin graft
8.5
40.4
91
114
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.7
39.9
312
1326
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.7
39.4
307
1302
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
39.3
345
1569
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
17.6
38.7
61
36
C49.23
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip leiomyosarcoma
+∞
38.7
37
*
159
Kela drug reimbursment
Pazopanib
+∞
38.7
37
*
R18
ICD-10 Finland
Ascites
12.4
37.9
69
58
ZZR00
NOMESCO Finland
Flap of skin
19.1
37.3
57
31
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.5
37.0
192
615
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
36.6
35
*
8800/3-C49.2
ICD-O-3
Sarcoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
36.6
35
*
C49.19
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder other or unspecified tumor
+∞
36.6
35
*
J01MA12
ATC
levofloxacin; systemic
2.5
35.7
319
1453
C57.9
ICD-10 Finland
Malignant neoplasm: Female genital organ, unspecified
+∞
35.6
34
*
C49.10
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder without histology
+∞
35.6
34
*
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
+∞
35.6
34
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
35.6
34
*
XW000
NOMESCO Finland
Bone marrow biopsy
6.4
35.3
96
159
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
34.5
33
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
34.5
33
*
C49.49
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen other or unspecified tumor
+∞
34.5
33
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
34.5
33
*
A06AH03
ATC
naloxegol; oral
23.0
34.1
49
22
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
345.0
34.1
34
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.8
34.0
155
445
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
25.5
33.7
47
19
N03AX16
ATC
pregabalin; oral
2.3
33.7
374
1900
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
33.5
32
*
C48.09
ICD-10 Finland
Malignant tumor of the retroperitoneal space other or unspecified tumor
+∞
33.5
32
*
8890/3-C49.2
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
33.5
32
*
R50.9
ICD-10 Finland
Fever, unspecified
2.9
33.4
233
912
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
14.5
33.1
56
40
C46.0
ICD-10 Finland
Kaposi sarcoma of skin
334.5
33.0
33
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
32.4
31
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
32.4
31
*
C49.39
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax other or unspecified tumor
+∞
32.4
31
*
L01XE11
ATC
[U] pazopanib; oral
+∞
32.4
31
*
9051/3-C38.4
ICD-O-3
Fibrous mesothelioma, malignant of pleura, NOS
+∞
32.4
31
*
C48.00
ICD-10 Finland
Malignant tumor of the retroperitoneal space without histology
+∞
32.4
31
*
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
168.7
31.8
33
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
116.0
31.8
34
*
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
37.4
31.6
40
11
ZZR10
NOMESCO Finland
Flap of skin and muscle
54.2
31.4
37
7
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
7.9
31.0
72
95
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
7.6
31.0
74
102
C49.21
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip malignant fibrotic histiocytoma
+∞
30.3
29
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.0
29.7
186
675
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
16.2
29.1
47
30
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
297.7
28.9
29
*
N02AX02
ATC
tramadol; systemic, rectal
1.9
28.5
594
3873
R84
ICPC
Malignant neoplasm bronchus/lung
+∞
28.2
27
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
28.2
27
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
8.0
28.2
65
85
JAL00
NOMESCO Finland
Biopsy of peritoneum
39.8
28.1
35
9
JAH00
NOMESCO Finland
Laparotomy
6.8
28.0
72
111
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
33.5
27.9
36
11
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
33.5
27.9
36
11
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
8.6
27.7
61
74
D38.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pleura
147.9
27.7
29
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
27.2
26
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
27.2
26
*
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
37.5
26.2
33
9
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.7
26.2
202
834
C49.99
ICD-10 Finland
Malignant tumor in unspecified localization in connective tissue and soft tissue other or unspecified tumor
+∞
26.1
25
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
26.1
25
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
4.4
25.9
97
232
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
95.2
25.7
28
*
R4120
NOMESCO Finland
Occupational therapy
3.4
25.7
132
416
WX306
NOMESCO Finland
Lumbar epidural anesthesy
4.2
25.6
102
259
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
6.4
25.4
68
111
C38.4
ICD-10 Finland
Malignant neoplasm: Pleura
+∞
25.1
24
*
C48.03
ICD-10 Finland
Malignant tumor of the retroperitoneal space leiomyosarcoma
+∞
25.1
24
*
C49.30
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax without histology
+∞
25.1
24
*
J94.9
ICD-10 Finland
Pleural condition, unspecified
16.4
25.0
40
25
ZX112
NOMESCO Finland
Subcutaneous
14.4
24.9
42
30
NGR30
NOMESCO Finland
Extensive or radikal excision of tumor of knee or lower leg
254.3
24.7
25
*
N02BE01
ATC
paracetamol; systemic, rectal
2.0
24.6
1152
9731
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
10.1
24.6
49
50
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
6.1
24.6
68
116
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
7.2
24.4
60
87
JN6AD
NOMESCO Finland
CT of torso and neck
20.5
24.4
36
18
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
35.2
24.3
31
9
8850/3-C49.6
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
24.0
23
*
C49.12
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder liposarcoma
+∞
24.0
23
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
24.0
23
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
38.3
24.0
30
8
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
38.3
24.0
30
8
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.8
23.8
165
637
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
127.1
23.6
25
*
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
17.6
23.2
36
21
C49.90
ICD-10 Finland
Malignant tumor in unspecified localization in connective tissue and soft tissue without histology
+∞
23.0
22
*
C48.0
ICD-10 Finland
Malignant neoplasm: Retroperitoneum
+∞
23.0
22
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
23.0
22
*
C49.11
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder malignant fibrotic histiocytoma
+∞
23.0
22
*
HA1AA
NOMESCO Finland
X-ray mammography
6.0
22.8
64
111
A02BC02
ATC
pantoprazole; systemic
1.8
22.8
861
6645
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
233.5
22.7
23
*
WX600
NOMESCO Finland
Single shot through catheter
14.4
22.7
38
27
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
121.9
22.6
24
*
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
7.6
22.5
53
72
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
5.3
22.5
70
138
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.4
22.2
83
199
343
Kela drug reimbursment
Pazopanib
+∞
21.9
21
*
8461/3-C48.1
ICD-O-3
High grade serous carcinoma of specified parts of peritoneum
+∞
21.9
21
*
L02BA01
ATC
tamoxifen; oral
63.5
21.9
25
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
63.5
21.9
25
*
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
223.2
21.6
22
*
S18
ICPC
Laceration/cut
1.8
21.4
560
3829
D17.2
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs
6.5
21.4
56
89
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.9
21.1
134
489
L02AE02
ATC
leuprorelin; implant, parenteral
16.9
21.0
33
20
L01BC06
ATC
capecitabine; oral
+∞
20.9
20
*
C49.4
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of abdomen
+∞
20.9
20
*
C49.28
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip Ewing's sarcoma
+∞
20.9
20
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
20.9
20
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
20.9
20
*
C49.59
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the pelvis other or unspecified tumor
+∞
20.9
20
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
20.9
20
*
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
21.9
20.8
30
14
HAC20
NOMESCO Finland
Total mastectomy
212.9
20.6
21
*
Z31.5
ICD-10 Finland
Genetic counselling
5.4
20.3
61
116
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
6.7
19.9
51
79
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
19.8
19
*
9680/3-C49.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of head, face, and neck
+∞
19.8
19
*
8850/3-C49.1
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
19.8
19
*
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
19.8
19
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
19.8
19
*
C49.25
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip fibrosarcoma
+∞
19.8
19
*
R4190
NOMESCO Finland
Nutritional therapy
5.4
19.8
60
115
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
74.5
19.7
22
*
N02AA01
ATC
morphine; systemic, rectal
10.5
19.7
38
37
KAC10
NOMESCO Finland
Total nephrectomy with capsule
106.5
19.6
21
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
19.7
19.5
29
15
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.3
19.5
104
337
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
9.1
19.2
40
45
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
3.2
19.0
102
332
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
55.8
19.0
22
*
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
4.7
18.9
65
144
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
18.8
18
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
18.8
18
*
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
18.8
18
*
L02BB03
ATC
bicalutamide; oral
+∞
18.8
18
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
+∞
18.8
18
*
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
70.8
18.7
21
*
GAE06
NOMESCO Finland
Excision of lesion of chest wall
101.4
18.6
20
*
JAH01
NOMESCO Finland
Laparoscopy
4.3
18.4
70
171
1XC02
NOMESCO Finland
NA
19.6
18.2
27
14
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.4
17.8
160
711
C49.00
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the head, face and neck without histology
+∞
17.7
17
*
YX9VG
NOMESCO Finland
Other MRI eamination with high intensity magnet for dose design of radiotherapy
+∞
17.7
17
*
9140/3-C44.7
ICD-O-3
Kaposi sarcoma of skin of lower limb and hip
+∞
17.7
17
*
C49.42
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen liposarcoma
+∞
17.7
17
*
8858/3-C48.0
ICD-O-3
Dedifferentiated liposarcoma of retroperitoneum
+∞
17.7
17
*
9053/3-C38.4
ICD-O-3
Mesothelioma, biphasic, malignant of pleura, NOS
+∞
17.7
17
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
5.8
17.6
50
89
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
8.2
17.6
39
49
C90.0
ICD-10 Finland
Multiple myeloma
182.1
17.5
18
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
182.1
17.5
18
*
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
16.2
17.0
27
17
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
10.2
16.9
33
33
C49.09
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the head, face and neck other or unspecified tumor
+∞
16.7
16
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
16.7
16
*
C49.3
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of thorax
+∞
16.7
16
*
8890/3-C49.1
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
16.7
16
*
L01CB01
ATC
etoposide; systemic
+∞
16.7
16
*
189
Kela drug reimbursment
Imatinib
+∞
16.7
16
*
C49.1
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of upper limb, including shoulder
+∞
16.7
16
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
16.7
16
*
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
8.1
16.6
37
47
NB1DG
NOMESCO Finland
Shoulder and humerus very extensive MRI examination with high intensity magnet
11.8
16.6
30
26
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
4.7
16.3
56
124
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
7.5
16.3
38
52
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
30.4
16.1
21
7
NG1DG
NOMESCO Finland
Knee and lower leg very extensive MRI examination with high intensity magnet
30.4
16.1
21
7
SPAT1109
SPAT
Analgesia with portable analgesic pump
16.9
16.1
25
15
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
24.8
16.0
22
9
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
24.8
16.0
22
9
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
24.8
16.0
22
9
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
10.9
16.0
30
28
TQW11
NOMESCO Finland
Vacuum treatment of wound
5.9
15.9
44
76
WX110
NOMESCO Finland
Local anesthesy
1.6
15.9
798
6349
KAC00
NOMESCO Finland
Nephrectomy
60.7
15.8
18
*
TK800
NOMESCO Finland
Hemodialysis
5.1
15.7
49
98
LCD00
NOMESCO Finland
Hysterectomy
3.7
15.7
69
193
C49.9
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue, unspecified
+∞
15.6
15
*
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
+∞
15.6
15
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
15.6
15
*
C48.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of retroperitoneum and peritoneum
+∞
15.6
15
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
+∞
15.6
15
*
C56
ICD-10 Finland
Malignant neoplasm of ovary
+∞
15.6
15
*
L71
ICPC
Malignant neoplasm musculoskeletal
+∞
15.6
15
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
15.6
15
*
8802/3-C49.2
ICD-O-3
Giant cell sarcoma of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
15.6
15
*
GAA31
NOMESCO Finland
Thoracoscopy
17.4
15.6
24
14
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
86.0
15.6
17
*
QD9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in lower extremities, unspecified
13.9
15.5
26
19
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
161.6
15.5
16
*
GA1CG
NOMESCO Finland
Extensive MRI of chest
38.5
15.4
19
5
ZXA00
NOMESCO Finland
Right side
1.7
15.2
373
2444
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
45.5
15.1
18
*
QBC00
NOMESCO Finland
Removal of foreign body from skin of trunk or subcutaneous tissue
57.3
14.8
17
*
C57.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of female genital organs
+∞
14.6
14
*
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
+∞
14.6
14
*
8850/3-C48.0
ICD-O-3
Liposarcoma, NOS, of retroperitoneum
+∞
14.6
14
*
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
+∞
14.6
14
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
14.6
14
*
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
+∞
14.6
14
*
8800/3-C49.1
ICD-O-3
Sarcoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
14.6
14
*
GDD20
NOMESCO Finland
Extended pneumonectomy
+∞
14.6
14
*
L01XE01
ATC
[U] imatinib; oral
+∞
14.6
14
*
C48.29
ICD-10 Finland
Malignant tumor in unspecified localization in peritoneum other or unspecified histology
+∞
14.6
14
*
C49.15
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder fibrosarcoma
+∞
14.6
14
*
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
6.1
14.6
39
65
JEA00
NOMESCO Finland
Appendectomy
2.9
14.5
88
312
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.3
14.5
141
652
B01AB04
ATC
dalteparin; parenteral
2.9
14.1
85
300
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.2
14.0
53
130
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
11.5
13.8
25
22
NGR20
NOMESCO Finland
Intralesional or marginal excision of tumor of knee or lower leg
75.8
13.6
15
*
A04AA03
ATC
tropisetron; systemic
75.8
13.6
15
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
75.8
13.6
15
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
13.6
13
*
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
+∞
13.6
13
*
8830/3-C49.2
ICD-O-3
Malignant fibrous histiocytoma of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
13.6
13
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
13.6
13
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
13.6
13
*
C49.43
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen leiomyosarcoma
+∞
13.6
13
*
C76.2
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Abdomen
+∞
13.6
13
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
13.6
13
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
13.6
13
*
C48.19
ICD-10 Finland
Malignant tumor in specified location in peritoneum other or unspecified histlogy
+∞
13.6
13
*
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
+∞
13.6
13
*
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
+∞
13.6
13
*
C49.13
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder leiomyosarcoma
+∞
13.6
13
*
C45
ICD-10 Finland
Mesothelioma
+∞
13.6
13
*
C48.80
ICD-10 Finland
Overall malignant tumor of the peritoneum and retroperitoneum without histology
+∞
13.6
13
*
C49.32
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax liposarcoma
+∞
13.6
13
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
13.6
13
*
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
11.0
13.5
25
23
ZXA05
NOMESCO Finland
Left side
1.7
13.5
343
2258
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
141.2
13.5
14
*
GAC43
NOMESCO Finland
Total decortication of pleura
141.2
13.5
14
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
141.2
13.5
14
*
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
141.2
13.5
14
*
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
141.2
13.5
14
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
13.4
362
2424
NBR20
NOMESCO Finland
Intralesional or marginal excision of soft tissue tumour of shoulder or upper arm
21.4
13.3
19
9
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
21.4
13.3
19
9
NJ3DG
NOMESCO Finland
Very extensive MRI examination of extremities with high intensity magnet
40.4
13.2
16
*
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
16.9
13.0
20
12
NAR20
NOMESCO Finland
Complete excision of soft tissue tumour of spine, unspecified
28.6
13.0
17
6
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
5.5
12.7
37
69
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
7.6
12.7
29
39
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
3.8
12.6
53
144
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
32.3
12.6
16
5
J01MA14
ATC
moxifloxacin; systemic
2.2
12.5
128
604
9040/3-C49.2
ICD-O-3
Synovial sarcoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
12.5
12
*
8890/3-C48.0
ICD-O-3
Leiomyosarcoma, NOS, of retroperitoneum
+∞
12.5
12
*
C45.7
ICD-10 Finland
Mesothelioma of other sites
+∞
12.5
12
*
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
+∞
12.5
12
*
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
+∞
12.5
12
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
12.5
12
*
D77
ICPC
Malignant digestive neopl other/NOS
+∞
12.5
12
*
C48.20
ICD-10 Finland
Malignant tumor in unspecified localization in the peritoneum without histology
+∞
12.5
12
*
C49.5
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of pelvis
+∞
12.5
12
*
8890/3-C49.4
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues of abdomen
+∞
12.5
12
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
12.5
12
*
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
+∞
12.5
12
*
9680/3-C49.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
12.5
12
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
12.5
12
*
R85
ICPC
Malignant neopl respiratory other
131.1
12.4
13
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
131.1
12.4
13
*
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
131.1
12.4
13
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.5
12.3
97
403
ZX050
NOMESCO Finland
Stereotactic radiotherapy
37.9
12.2
15
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.3
12.2
109
486
ZZR30
NOMESCO Finland
Flap of muscle
16.0
12.1
19
12
JAA10
NOMESCO Finland
Excision of lesion of abdominal wall
26.9
12.0
16
6
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
26.9
12.0
16
6
Y77
ICPC
Malignant neoplasm prostate
47.0
11.9
14
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
5.7
11.8
33
59
R22.3
ICD-10 Finland
Localized swelling, mass and lump, upper limb
5.0
11.8
37
76
JN3AD
NOMESCO Finland
Abdominal CT examination
2.4
11.7
97
414
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
16.6
11.7
18
11
Q85.00
ICD-10 Finland
Neurofibromatosis, type 1
30.3
11.6
15
5
R82
ICPC
Pleurisy/pleural effusion
30.3
11.6
15
5
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.3
11.6
105
470
GAC97
NOMESCO Finland
Other endoscopic operation on pleura
19.1
11.6
17
9
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.6
11.6
83
327
C49.60
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue at the torso, unspecified location without histology
+∞
11.5
11
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
+∞
11.5
11
*
GAC30
NOMESCO Finland
Artificial pneumothorax
+∞
11.5
11
*
C49.52
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the pelvis liposarcoma
+∞
11.5
11
*
C46.9
ICD-10 Finland
Kaposi sarcoma, unspecified
+∞
11.5
11
*
8811/3-C49.2
ICD-O-3
Myxofibrosarcoma of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
11.5
11
*
C49.0
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of head, face and neck
+∞
11.5
11
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
11.5
11
*
17131
ICD-8 Finland
Malignant neoplasm of connective and other soft tissue, Lower limb (including hip)
+∞
11.5
11
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
11.5
11
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
11.5
11
*
C26.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the digestive system
+∞
11.5
11
*
C49
ICD-10 Finland
Malignant neoplasm of other connective and soft tissue
+∞
11.5
11
*
GDD96
NOMESCO Finland
Other pneumonectomy
+∞
11.5
11
*
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
+∞
11.5
11
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
11.5
11
*
3AA13
NOMESCO Finland
NA
+∞
11.5
11
*
C48.2
ICD-10 Finland
Malignant neoplasm: Peritoneum, unspecified
+∞
11.5
11
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
11.5
11
*
8850/3-C49.4
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of abdomen
+∞
11.5
11
*
H02AB06
ATC
prednisolone; systemic
1.5
11.4
589
4579
TQW99
NOMESCO Finland
Other minor procedure on skin
3.2
11.4
59
190
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
4.7
11.2
37
80
SPAT1153
SPAT
Removal of sutures
1.6
11.2
389
2762
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
12.8
11.1
19
15
N05CF01
ATC
zopiclone; oral
1.5
11.1
424
3076
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
5.9
11.0
30
52
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
3.8
10.9
45
121
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
7.9
10.9
24
31
R52.0
ICD-10 Finland
Acute pain
3.8
10.8
45
122
XX1XW
NOMESCO Finland
Extensive written report from radiologist
4.5
10.8
37
84
GA1BG
NOMESCO Finland
MRI of chest
28.2
10.7
14
5
N05BA06
ATC
lorazepam; systemic, sublingual
2.5
10.7
82
337
J86.9
ICD-10 Finland
Pyothorax without fistula
6.8
10.7
26
39
SPAT1088
SPAT
Blood transfusion
13.0
10.7
18
14
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
3.4
10.5
49
146
D17.1
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk
3.4
10.5
50
152
WW409
NOMESCO Finland
Other aferesis
110.8
10.4
11
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
+∞
10.4
10
*
C49.53
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the pelvis leiomyosarcoma
+∞
10.4
10
*
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
+∞
10.4
10
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
10.4
10
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
10.4
10
*
X77
ICPC
Malignant neopl genital female other
+∞
10.4
10
*
XX9CD
NOMESCO Finland
Very extensive complementary CT
+∞
10.4
10
*
8852/3-C49.2
ICD-O-3
Myxoid liposarcoma of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
10.4
10
*
8830/3-C49.1
ICD-O-3
Malignant fibrous histiocytoma of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
10.4
10
*
YNB10
NOMESCO Finland
Collection of stem cells for transplant
+∞
10.4
10
*
GAE23
NOMESCO Finland
Resection of chest wall and prosthetic repair
+∞
10.4
10
*
YN1CD
NOMESCO Finland
Very extensive CT examination of extremities for dose design of radiotherapy
+∞
10.4
10
*
C49.02
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the head, face and neck liposarcoma
+∞
10.4
10
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
10.4
10
*
8830/3-C49.6
ICD-O-3
Malignant fibrous histiocytoma of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
10.4
10
*
C49.31
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax malignant fibrotic histiocytoma
+∞
10.4
10
*
9680/3-C49.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues, NOS
+∞
10.4
10
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
10.4
10
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
10.4
10
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
10.4
10
*
C49.98
ICD-10 Finland
Malignant tumor in unspecified localization in connective tissue and soft tissue Ewing's sarcoma
+∞
10.4
10
*
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
+∞
10.4
10
*
ZZF00
NOMESCO Finland
Graft of adipose tissue
18.9
10.3
15
8
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
23.5
10.2
14
6
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
6.3
10.2
26
42
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
13.2
10.2
17
13
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.2
10.1
98
455
WW200
NOMESCO Finland
Immunization
3.5
10.1
45
130
PJA10
NOMESCO Finland
Exploration of lymph nodes
11.4
10.1
18
16
GD1CG
NOMESCO Finland
Extensive examination of lungs and pleura with high intensity magnet
40.3
10.0
12
*
GDC00
NOMESCO Finland
Lobectomy of lung
40.3
10.0
12
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
4.2
9.9
36
87
TNG34
NOMESCO Finland
Major custom moulded orthopaedic cast, knee or lower leg
5.1
9.9
30
60
ZXC96
NOMESCO Finland
Robot assisted procedure
12.3
9.9
17
14
JMA10
NOMESCO Finland
Transabdominal total splenectomy
12.3
9.9
17
14
TPX15
NOMESCO Finland
Removal of vascular injection port
20.2
9.8
14
7
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
4.9
9.8
31
65
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
9.6
9.8
19
20
JFB30
NOMESCO Finland
Right hemicolectomy
7.4
9.7
22
30
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
13.5
9.7
16
12
XW4CT
NOMESCO Finland
Biopsy of other inner organ with CT guidance
55.3
9.7
11
*
B03BA03
ATC
hydroxocobalamin; parenteral
2.2
9.6
95
445
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
15.1
9.5
15
10
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
9.4
210
1318
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
100.6
9.4
10
*
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
100.6
9.4
10
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.4
9.4
80
349
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
4.2
9.4
34
82
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
9.4
9
*
YJ1CD
NOMESCO Finland
Very extensive CT examination of abdomen for dose design of radiotherapy
+∞
9.4
9
*
C49.69
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the torso, unspecified localization other or unspecified tumor
+∞
9.4
9
*
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
+∞
9.4
9
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
9.4
9
*
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
+∞
9.4
9
*
NCR30
NOMESCO Finland
Extended excision of soft tissue tumour of elbow or forearm
+∞
9.4
9
*
C49.04
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the head, face and neck rhabdomyosarcoma
+∞
9.4
9
*
C49.50
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the pelvis without histology
+∞
9.4
9
*
153
Kela drug reimbursment
Lenalidomid
+∞
9.4
9
*
8810/3-C49.1
ICD-O-3
Fibrosarcoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
9.4
9
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
9.4
9
*
C48.1
ICD-10 Finland
Malignant neoplasm: Specified parts of peritoneum
+∞
9.4
9
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
9.4
9
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
9.4
9
*
C49.03
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the head, face and neck Leiomyosarcoma
+∞
9.4
9
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
9.4
9
*
L04AX04
ATC
lenalidomide; oral
+∞
9.4
9
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
9.4
9
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
9.4
9
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
9.4
9
*
GA3AT
NOMESCO Finland
Pleural cytology with ultrasound guidance
12.4
9.4
16
13
J01FF01
ATC
clindamycin; systemic
1.5
9.3
320
2253
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
5.3
9.2
27
52
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
5.0
9.1
28
57
B03XA02
ATC
darbepoetin alfa; parenteral
4.3
9.1
32
75
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
11.5
9.1
16
14
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.7
9.0
59
223
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
36.9
9.0
11
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
9.0
356
2583
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.7
9.0
212
1352
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
4.6
9.0
30
67
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
5.3
8.9
26
50
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
24.2
8.9
12
5
Q85.09
ICD-10 Finland
Unspecified neurofibromatosis
24.2
8.9
12
5
Z42.4
ICD-10 Finland
Follow-up care involving plastic surgery of lower extremity
24.2
8.9
12
5
NK1XE
NOMESCO Finland
Other ultrasound examinnation of muscle or tendon
6.0
8.8
23
39
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
4.7
8.7
28
60
TQW40
NOMESCO Finland
Remowal of suture of skin
2.3
8.7
78
349
A41.9
ICD-10 Finland
Sepsis, unspecified
2.8
8.7
55
203
JFB43
NOMESCO Finland
Left hemicolectomy
14.1
8.7
14
10
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
50.3
8.7
10
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
50.3
8.7
10
*
TJF80
NOMESCO Finland
Ostomy education
16.4
8.6
13
8
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
6.4
8.5
21
33
QC9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in upper extremities, unspecified
27.7
8.5
11
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
90.5
8.4
9
*
1CX01
NOMESCO Finland
NA
90.5
8.4
9
*
GAC46
NOMESCO Finland
Partial decortication of pleura
90.5
8.4
9
*
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
90.5
8.4
9
*
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
8.3
8
*
D74
ICPC
Malignant neoplasm stomach
+∞
8.3
8
*
8810/3-C49.2
ICD-O-3
Fibrosarcoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
8.3
8
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
8.3
8
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
8.3
8
*
GD2FN
NOMESCO Finland
Lung ventilation distribution isotope examination (radiospirometry)
+∞
8.3
8
*
WC115
NOMESCO Finland
Cytostatic therapy of local tumor recidive with multiple drugs
+∞
8.3
8
*
JGB03
NOMESCO Finland
Partial proctectomy with partial excision of mesorectum
+∞
8.3
8
*
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
+∞
8.3
8
*
8720/3-C44.6
ICD-O-3
Malignant melanoma, NOS, of skin of upper limb and shoulder
+∞
8.3
8
*
GA2AT
NOMESCO Finland
Pleural biopsy with ultrasound guidance
+∞
8.3
8
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
8.3
8
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
8.3
8
*
9680/3-C48.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of retroperitoneum
+∞
8.3
8
*
WX1DG
NOMESCO Finland
Very extensive total body MRI with high intensity magnet
+∞
8.3
8
*
9052/3-C48.2
ICD-O-3
Epithelioid mesothelioma, malignant of peritoneum, NOS
+∞
8.3
8
*
1638X
ICD-9 Finland
Malignant neoplasm of pleura, Other specified sites of pleura
+∞
8.3
8
*
C77.4
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes
+∞
8.3
8
*
C74.1
ICD-10 Finland
Malignant neoplasm: Medulla of adrenal gland
+∞
8.3
8
*
C90.2
ICD-10 Finland
Extramedullary plasmacytoma
+∞
8.3
8
*
C43.99
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin other or unspecified histology
+∞
8.3
8
*
B72
ICPC
Hodgkin Lymphoma
+∞
8.3
8
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
8.3
8
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
8.3
8
*
9680/3-C49.3
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of thorax
+∞
8.3
8
*
L02BX02
ATC
degarelix; parenteral
+∞
8.3
8
*
NAR40
NOMESCO Finland
Block excision of soft tissue tumour of spine, unspecified
+∞
8.3
8
*
8811/3-C49.1
ICD-O-3
Myxofibrosarcoma of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
8.3
8
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
8.3
8
*
C80.99
ICD-10 Finland
Malignant tumor without specified localization or histology
+∞
8.3
8
*
C49.18
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder Ewing's sarcoma
+∞
8.3
8
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
+∞
8.3
8
*
C49.40
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen without histology
+∞
8.3
8
*
C48.22
ICD-10 Finland
Malignant tumor in unspecified localization in peritoneum liposarcoma
+∞
8.3
8
*
WX002
NOMESCO Finland
Sedation and analgesia
1.6
8.3
236
1581
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
3.9
8.3
32
83
C03CA01
ATC
furosemide; systemic
1.4
8.2
435
3344
Q85.0
ICD-10 Finland
Neurofibromatosis (nonmalignant)
33.5
8.1
10
*
WF099
NOMESCO Finland
Other radiotherapy
17.3
8.1
12
7
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
3.9
8.1
31
80
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
2.6
8.0
55
213
KCD02
NOMESCO Finland
Transurethral resection of bladder
10.1
8.0
15
15
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
3.1
8.0
42
139
TKE00
NOMESCO Finland
Needle biopsy of prostate
3.0
7.9
45
155
GAC37
NOMESCO Finland
Endoscopic chemical pleurodesis
45.2
7.7
9
*
NE1CM
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with 3 Tesla magnet
15.1
7.7
12
8
S77
ICPC
Malignant neoplasm of skin
15.1
7.7
12
8
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
7.7
227
1534
WVA20
NOMESCO Finland
Medicine administration
3.9
7.7
30
79
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
2.1
7.6
79
380
SPAT1053
SPAT
Memory test
0.6
7.6
101
1678
LAF00
NOMESCO Finland
Unilateral salpingo-oophorectomy
8.1
7.6
16
20
TGC00
NOMESCO Finland
Bronchial lavation
3.0
7.6
41
139
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
25.1
7.6
10
*
9474
FHL
Soft tissue tumor removal (subcutaneous tumor 9736 skin tumor 9733)
25.1
7.6
10
*
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
5.4
7.5
21
39
JFB00
NOMESCO Finland
Partial resection of small intestine
4.4
7.5
25
57
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
80.5
7.4
8
*
GDB10
NOMESCO Finland
Wedge resection of lung
80.5
7.4
8
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
80.5
7.4
8
*
WX1CG
NOMESCO Finland
Extensive total body MRI with high intensity magnet
80.5
7.4
8
*
1XC07
NOMESCO Finland
NA
80.5
7.4
8
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
7.7
7.4
16
21
NG4AA
NOMESCO Finland
Lower leg X-ray examination
3.1
7.4
38
125
M04AA01
ATC
allopurinol; systemic
1.6
7.3
182
1175
A06AD11
ATC
lactulose; oral
1.6
7.3
191
1249
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
8.4
7.3
15
18
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.4
7.3
24
632
8851/3-C49.2
ICD-O-3
Liposarcoma, well differentiated, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
7.3
7
*
FM1FN
NOMESCO Finland
Heart function isotope examination
+∞
7.3
7
*
GAE20
NOMESCO Finland
Resection of chest wall and repair using flap
+∞
7.3
7
*
1580A
ICD-9 Finland
Malignant neoplasm of retroperitoneum and peritoneum, Retroperitoneum
+∞
7.3
7
*
C40.29
ICD-10 Finland
Malignant tumor of the long bones of the lower extremity other or unspecified histology
+∞
7.3
7
*
C34.92
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma
+∞
7.3
7
*
C40.2
ICD-10 Finland
Malignant neoplasm: Long bones of lower limb
+∞
7.3
7
*
180
Kela drug reimbursment
Interferon alfa
+∞
7.3
7
*
9680/3-C49.4
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of abdomen
+∞
7.3
7
*
GA2CT
NOMESCO Finland
Pleural biopsy with CT guidance
+∞
7.3
7
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
7.3
7
*
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
+∞
7.3
7
*
9680/3-C49.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
7.3
7
*
1713K
ICD-9 Finland
Malignant neoplasm of connective and other soft tissue, Lower limb, including hip[ALARAAJAN PEHMYTKUDOSSYÖPÄ,MUU HISTOL]
+∞
7.3
7
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
7.3
7
*
C49.89
ICD-10 Finland
Overall malignant tumor of connective tissue and other soft tissue other or unspecified tumor
+∞
7.3
7
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
7.3
7
*
1CD02
NOMESCO Finland
NA
+∞
7.3
7
*
8800/3-C49.9
ICD-O-3
Sarcoma, NOS, of connective, Subcutaneous and other soft tissues, NOS
+∞
7.3
7
*
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
7.3
7
*
9680/3-C49.6
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
7.3
7
*
C49.24
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip rhabdomyosarcoma
+∞
7.3
7
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
7.3
7
*
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
+∞
7.3
7
*
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
+∞
7.3
7
*
Z52.89
ICD-10 Finland
Donor of other organ or tissue
+∞
7.3
7
*
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
+∞
7.3
7
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
7.3
7
*
9050/3-C48.2
ICD-O-3
Mesothelioma, malignant of peritoneum, NOS
+∞
7.3
7
*
WX1BG
NOMESCO Finland
Total body MRI with high intensity magnet
+∞
7.3
7
*
1990X
ICD-9 Finland
Malignant neoplasm without specification of site, Disseminated
+∞
7.3
7
*
8800/3-C49.6
ICD-O-3
Sarcoma, NOS, of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
7.3
7
*
NER30
NOMESCO Finland
Extended excision of soft tissue tumour of pelvis
+∞
7.3
7
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
8811/3-C49.5
ICD-O-3
Myxofibrosarcoma of connective, Subcutaneous and other soft tissues of pelvis
+∞
7.3
7
*
GEB30
NOMESCO Finland
Mediastinotomy and excision of lesion
+∞
7.3
7
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.1
7.2
37
121
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
15.8
7.2
11
7
Z51.88
ICD-10 Finland
Other specified medical care
3.5
7.2
32
94
NF3AA
NOMESCO Finland
Femur X-ray examination
3.6
7.2
30
84
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
30.2
7.1
9
*
TJA10
NOMESCO Finland
Laparocentesis
30.2
7.1
9
*
J93.8
ICD-10 Finland
Other pneumothorax
12.1
7.1
12
10
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
7.0
175
1134
GAB10
NOMESCO Finland
Antero- or postero-lateral thoracotomy
10.1
7.0
13
13
XX9XW
NOMESCO Finland
NA
7.0
7.0
16
23
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
6.9
552
4527
JAG60
NOMESCO Finland
Reconstruction of abdominal wall using prosthetic material
13.8
6.9
11
8
KBV00
NOMESCO Finland
Insertion of stent into ureter
9.4
6.8
13
14
JFB46
NOMESCO Finland
Resection of sigmoid colon
5.7
6.8
18
32
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
40.2
6.8
8
*
NHR30
NOMESCO Finland
Complete excision of soft tissue tumour of ankle or foot
40.2
6.8
8
*
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
40.2
6.8
8
*
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
16.8
6.7
10
6
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
2.8
6.7
40
145
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
2.6
6.6
44
170
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
7.8
6.6
14
18
WX892
NOMESCO Finland
Monitored bed care
1.9
6.6
98
545
TQB05
NOMESCO Finland
Puncture of skin of trunk
12.3
6.6
11
9
SPAT1255
SPAT
Intravenous administration of medicine
2.0
6.5
79
406
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
3.2
6.5
32
103
Z42.2
ICD-10 Finland
Follow-up care involving plastic surgery of other parts of trunk
70.1
6.4
7
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
70.1
6.4
7
*
DM1CG
NOMESCO Finland
Paranasal sinuses and face area extensive MRI examination with high intensity magnet
70.1
6.4
7
*
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
14.4
6.4
10
7
ZX108
NOMESCO Finland
Inhalation
8.2
6.3
13
16
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.9
6.3
36
125
S04
ICPC
Lump/swelling localized
1.9
6.3
95
529
N06DX01
ATC
memantine; oral
0.4
6.3
28
652
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
18.1
6.3
9
5
C46.7
ICD-10 Finland
Kaposi sarcoma of other sites
+∞
6.3
6
*
JAQ00
NOMESCO Finland
Extensive excision of peritoneum
+∞
6.3
6
*
H01CB03
ATC
lanreotide; parenteral
+∞
6.3
6
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
6.3
6
*
C43.60
ICD-10 Finland
Malignant melanoma of the upper extremity including the shoulder without histology
+∞
6.3
6
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
6.3
6
*
9500/3-C47.4
ICD-O-3
Neuroblastoma, NOS, of peripheral nerves and autonomic nervous system of abdomen
+∞
6.3
6
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
6.3
6
*
L01AX03
ATC
temozolomide; systemic
+∞
6.3
6
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
6.3
6
*
C49.54
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the pelvis rhabdomyosarcoma
+∞
6.3
6
*
C49.33
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the chest leiomyosarcoma
+∞
6.3
6
*
1510
Kela drug reimbursment
Niraparib
+∞
6.3
6
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
6.3
6
*
3009
Kela drug reimbursment
Niraparib
+∞
6.3
6
*
329
Kela drug reimbursment
Lenalidomide
+∞
6.3
6
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
6.3
6
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
+∞
6.3
6
*
C49.35
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thoracic fibrosarcoma
+∞
6.3
6
*
L02BG06
ATC
exemestane; oral
+∞
6.3
6
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
6.3
6
*
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
+∞
6.3
6
*
WW402
NOMESCO Finland
Leucoferesis
+∞
6.3
6
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
6.3
6
*
C46.3
ICD-10 Finland
Kaposi sarcoma of lymph nodes
+∞
6.3
6
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
6.3
6
*
8890/3-C49.6
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
6.3
6
*
9560/3-C47.9
ICD-O-3
Neurilemoma, malignant of autonomic nervous system, NOS
+∞
6.3
6
*
8460/3-C48.2
ICD-O-3
Low grade serous carcinoma of peritoneum, NOS
+∞
6.3
6
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
6.3
6
*
C49.91
ICD-10 Finland
Malignant tumor in unspecified localization in connective tissue and soft tissue malignant fibrotic histiocytoma
+∞
6.3
6
*
8850/3-C49.5
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of pelvis
+∞
6.3
6
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
6.3
6
*
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
26.8
6.2
8
*
9734
FHL
Excision and local plastic or associated free skin grafting
7.1
6.2
14
20
D21.1
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder
5.0
6.2
18
36
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.9
6.1
35
122
N06DA03
ATC
rivastigmine; oral, transdermal
0.3
6.1
9
348
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
6.7
6.0
14
21
QCE99
NOMESCO Finland
Other excision or repair of lesion of skin of upper limb
10.1
6.0
11
11
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
5.2
6.0
17
33
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.1
6.0
60
286
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
855
575
21.83
307.65
1.5
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
629
1067
7.49
307.65
3.1
1.4
ug/l
5.9
14.6
0.35
460
795
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
385
595
7.44
244.04
13.1
1.5
u/ml
184.7
27.7
6.55
376
562
(40768806) Pleura Pathology biopsy report
210
149
15.27
233.51
2.1
1.5
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
691
1983
4.40
218.95
5.1
2.9
u/l
259.1
235.2
1.13
675
1841
(3003434) Protein [Mass/volume] in Pleural fluid
232
221
11.45
215.12
1.7
1.5
g/l
38.6
28.3
18.66
221
195
(3012095) Magnesium [Moles/volume] in Serum or Plasma
856
2906
3.92
214.18
5.5
2.7
mmol/l
0.8
0.8
7.77
825
2662
(3028308) Erythrocytes [#/volume] in Pleural fluid
208
177
12.70
207.48
1.8
1.5
e6/l
37988.6
78525.6
0.53
139
102
(40768804) Tissue Pathology biopsy report
1348
6241
3.45
206.59
2.9
1.7
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
216
202
11.59
202.61
1.8
1.5
e6/l
1457.2
1720.6
0.45
166
141
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
289
400
8.02
201.01
2.6
1.8
u/ml
133.8
82.9
0.32
244
315
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1722
9546
3.46
190.59
12.6
3.8
umol/l
10.6
12.3
4.47
1683
8903
(3012441) Differential panel - Pleural fluid
193
171
12.13
187.40
1.8
1.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
1210
5562
3.23
181.76
3.4
2.2
—
—
—
0
0
(3002256) Pathology report gross observation
545
1504
4.33
179.04
1.5
1.1
—
—
—
0
0
(4281824)
145
94
16.29
168.67
1.4
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1003
4296
3.20
167.22
3.2
2.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1534
8449
3.04
161.36
5.3
3.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
1140
5367
3.03
159.24
5.4
3.9
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
1761
10694
3.08
150.90
19.3
6.3
e9/l
4.3
4.3
0.29
1585
9133
(3024561) Albumin [Mass/volume] in Serum or Plasma
1492
8324
2.90
149.08
8.2
3.9
g/l
33.2
35.5
35.74
1432
7583
(3042936) Bacteria identified in Isolate by Culture
718
2697
3.31
146.60
2.2
2.0
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
156
150
11.01
143.03
1.5
1.3
mmol/l
4.9
7.3
9.01
149
136
(3033658) Prothrombin time (PT) actual/Normal
1008
4649
2.93
142.93
6.3
3.5
%
89.4
86.3
3.94
986
4519
(3045788) Cell count panel - Pleural fluid
157
162
10.26
136.93
1.8
1.5
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
89
31
29.71
133.88
1.2
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
200
345
6.20
112.00
1.8
1.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
1161
6323
2.53
111.71
7.5
2.1
mmol/l
2.3
2.4
1.86
1055
5241
(40758558) Short blood count panel - Blood
922
4510
2.63
111.09
14.8
4.7
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1478
9071
2.49
108.57
8.5
5.4
mmol/l
1.2
1.2
4.73
1404
8016
(40768795) Lymph node Pathology biopsy report
84
45
19.27
106.85
1.3
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
1385
8348
2.44
104.48
8.3
10.5
inr
1.2
1.3
7.03
326
2352
(42870588) Differential panel, method unspecified - Blood
1166
6509
2.45
104.44
7.2
5.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1550
10050
2.38
95.83
9.6
5.7
mmol/l
1.2
1.2
7.47
1349
8423
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
250
619
4.37
92.11
2.1
2.9
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
70
35
20.53
91.69
1.5
1.2
ug/l
38.6
31.2
0.06
30
14
(3035880) pH of Pleural fluid
92
83
11.46
87.73
1.4
1.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
1027
5799
2.29
85.14
6.2
3.2
ph
7.4
7.4
0.92
192
1007
(3022096) Basophils/100 leukocytes in Blood
1373
8731
2.24
85.00
8.0
5.7
%
0.6
0.7
3.84
1316
8026
(3002030) Lymphocytes/100 leukocytes in Blood
1424
9220
2.23
83.90
8.1
5.7
%
24.3
27.5
19.41
1362
8452
(3019069) Monocytes/100 leukocytes in Blood
1400
9016
2.22
83.43
8.2
5.9
%
9.1
8.8
2.80
1341
8317
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
735
3619
2.45
83.28
5.6
2.2
mmol/l
2.5
2.4
10.26
674
3080
(3020630) Protein [Mass/volume] in Serum or Plasma
442
1699
2.94
82.33
4.2
1.6
g/l
64.6
66.8
6.69
424
1505
(3006504) Eosinophils/100 leukocytes in Blood
1387
8979
2.19
80.54
8.0
5.6
%
2.7
3.0
4.98
1329
8250
(3001604) Monocytes [#/volume] in Blood
1453
9654
2.17
78.00
7.8
5.4
e9/l
0.6
0.6
0.86
1257
8224
(3006315) Basophils [#/volume] in Blood
1453
9715
2.15
75.94
7.8
5.4
e9/l
0.0
0.0
3.67
1258
8284
(3018010) Neutrophils/100 leukocytes in Blood
1388
9133
2.14
75.48
7.8
5.6
%
60.0
57.6
9.60
1336
8419
(3019198) Lymphocytes [#/volume] in Blood
1471
9900
2.14
75.34
7.9
5.4
e9/l
1.7
1.9
2.30
1287
8573
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1983
15056
2.41
74.83
14.9
5.4
u/l
86.7
77.5
10.43
1923
13867
(3003458) Phosphate [Moles/volume] in Serum or Plasma
568
2601
2.52
74.31
6.6
5.2
mmol/l
1.0
1.0
1.00
545
2387
(3014111) Lactate [Moles/volume] in Serum or Plasma
427
1724
2.77
71.90
8.0
6.6
mmol/l
1.2
1.4
5.06
419
1657
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
204
524
4.14
71.22
1.6
1.7
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
1470
10057
2.09
69.98
8.2
5.5
e9/l
0.2
0.2
1.98
1288
8689
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
190
472
4.27
69.32
2.3
2.5
g/l
3.8
3.5
0.93
183
444
(3003396) Base excess in Arterial blood by calculation
512
2302
2.53
69.17
7.8
6.9
mmol/l
0.7
1.3
2.71
431
1761
(3018677) aPTT in Platelet poor plasma by Coagulation assay
631
3139
2.34
67.99
2.8
2.0
s
29.9
30.0
0.13
612
3034
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
508
2310
2.50
66.78
7.8
6.9
kpa
5.2
5.1
1.44
496
2193
(3027801) Oxygen [Partial pressure] in Arterial blood
508
2310
2.50
66.78
7.8
6.9
kpa
14.2
11.6
15.85
493
2192
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
120
209
5.98
66.20
2.3
1.8
u/ml
33.6
64.3
0.79
104
187
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
453
1981
2.56
64.51
2.9
2.3
umol/l
8.4
8.4
0.01
408
1696
(3000991) Gas panel - Venous blood
399
1643
2.69
64.19
9.4
7.7
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
417
1759
2.64
63.91
7.9
6.9
mmol/l
8.6
10.7
6.95
403
1660
(3014576) Chloride [Moles/volume] in Serum or Plasma
522
2452
2.42
63.63
8.7
6.1
mmol/l
104.7
104.2
1.52
508
2391
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
176
442
4.20
63.22
2.3
2.4
%
213.5
187.0
2.89
170
418
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
185
484
4.04
62.87
2.2
2.3
%
88.9
89.4
0.10
177
458
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
212
624
3.61
60.79
2.8
3.4
u/ml
0.3
0.3
0.04
127
371
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
369
1505
2.70
60.29
2.2
2.1
g/l
0.2
0.2
0.04
350
1355
(3030467) Casts [#/volume] in Urine by Automated count
910
5461
2.03
59.48
3.3
3.0
e6/l
0.7
0.5
0.96
679
4073
(3044007) Cell count panel - Peritoneal fluid
52
36
14.72
57.98
1.5
2.4
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
54
41
13.43
57.16
1.5
1.8
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
333
1327
2.74
56.77
1.7
1.6
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
53
40
13.51
56.29
1.5
2.4
e6/l
14168.0
55260.0
0.38
26
21
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
384
1651
2.56
56.14
2.5
2.2
u/l
39.7
67.2
0.44
336
1374
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
276
1001
2.97
56.07
9.8
9.0
mmol/l
24.5
24.4
0.25
270
916
(3023487) Leukocytes [#/volume] in Peritoneal fluid
56
47
12.16
55.80
1.5
2.6
e6/l
1622.5
361.3
3.19
31
35
(3002582) Erythrocytes [#/volume] in Urine
959
5969
1.97
55.65
3.4
3.1
e6/l
44.0
83.7
1.49
729
4537
(3013826) Glucose [Moles/volume] in Serum or Plasma
1610
11927
1.94
54.99
6.8
4.4
mmol/l
6.8
6.8
0.06
1565
11106
(36304419) Bacteria [Presence] in Urine
872
5295
1.98
54.02
3.3
3.0
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
944
5891
1.95
53.98
5.7
2.6
u/l
32.6
35.2
0.71
904
5553
(3002173) Hemoglobin [Mass/volume] in Arterial blood
415
1894
2.42
53.18
8.9
7.5
g/l
115.8
121.6
7.44
407
1823
(3021879) Hepatitis B virus core Ab [Presence] in Serum
267
993
2.89
51.69
1.4
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
610
3319
2.10
50.76
2.1
1.8
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
94
167
5.81
50.75
2.4
1.6
u/ml
6.5
32.6
0.57
94
160
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
264
1016
2.78
47.82
9.8
10.0
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
429
2084
2.27
47.21
8.5
7.2
%
96.5
95.1
4.87
420
1998
(3014007) Fractional oxyhemoglobin in Arterial blood
296
1223
2.61
46.56
10.1
8.6
%
95.2
93.4
8.05
296
1218
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
114
259
4.56
46.48
1.3
1.3
—
—
—
0
0
(3036489) Thrombin time
192
628
3.22
46.40
2.1
2.0
s
22.0
21.2
0.80
183
550
(3018095) Leukocytes [#/volume] in Urine
1041
6991
1.82
45.34
4.4
3.5
e6/l
129.8
108.6
0.22
764
4887
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
559
3056
2.06
45.32
3.0
2.8
e6/l
2.5
2.5
0.04
291
1645
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
67
97
7.07
44.14
1.3
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1204
8563
1.77
42.28
14.1
8.5
e9/l
0.0
0.0
0.55
985
6919
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
583
3321
1.98
41.71
2.9
2.7
e6/l
1.2
1.3
0.11
316
1897
(3007853) Bacteria identified in Skin by Aerobe culture
441
2296
2.11
40.30
1.9
1.8
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
57
82
7.09
37.76
1.9
2.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
437
2320
2.07
37.71
1.9
1.7
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
38
32
12.04
37.69
1.1
1.5
g/l
37.7
22.2
4.26
33
27
(3011412) CD3 cells [#/volume] in Blood
67
115
5.96
37.47
2.2
2.1
e9/l
0.9
1.2
1.68
47
63
(3004809) Band form neutrophils/100 leukocytes in Blood
97
235
4.25
36.43
3.3
2.8
%
2.1
1.3
0.93
82
172
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
433
2319
2.04
36.38
1.9
1.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
337
1647
2.20
35.94
1.6
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
740
4763
1.78
35.17
1.4
1.3
—
—
—
0
0
(3026782) Osmolality of Urine
632
3887
1.83
34.93
2.7
2.6
mosm/kgh2o
533.6
547.6
0.85
531
3253
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
98
247
4.09
34.92
6.3
7.2
mg/l
11.9
11.9
0.03
92
230
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
55
86
6.51
33.73
1.9
2.2
%
14.5
13.6
0.16
24
45
(3004789) Transferrin [Mass/volume] in Serum or Plasma
500
2891
1.91
33.40
2.3
2.5
g/l
2.2
2.3
3.73
474
2653
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
891
6167
1.68
31.95
3.1
2.3
u/l
55.6
59.4
1.35
831
5637
(3045142) Bone marrow Pathology biopsy report
69
141
5.00
31.95
1.2
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
64
123
5.31
31.76
1.2
1.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
465
2674
1.90
31.41
2.4
2.6
%
21.4
22.7
1.11
408
2231
(3031040) Bacteria [#/volume] in Urine by Automated count
1628
13166
1.65
31.08
5.3
4.5
e6/l
184.2
2307.0
2.68
27
195
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
121
383
3.27
30.78
1.8
1.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
653
4192
1.75
30.62
2.7
2.4
e6/l
5.7
5.3
0.30
564
3619
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
100
281
3.66
30.58
1.9
1.5
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
98
273
3.69
30.35
3.7
5.4
iu/ml
157.5
490.2
—
10
32
(3022948) Iron [Moles/volume] in Serum or Plasma
521
3140
1.83
30.23
2.5
2.4
umol/l
11.9
13.0
2.31
487
2873
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
52
88
6.01
29.51
2.4
1.7
e6/l
252.4
782.1
5.89
13
39
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
121
394
3.17
29.37
1.8
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
74
174
4.35
28.91
2.7
3.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
31
30
10.45
28.03
2.1
3.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
114
379
3.10
26.73
1.3
1.7
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
22
13
17.06
26.36
7.1
1.2
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
33
40
8.34
25.26
1.2
1.6
g/l
19.8
13.3
2.29
27
28
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
345
1929
1.91
24.98
1.5
1.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
178
776
2.39
24.61
2.2
1.8
ug/l
1.1
1.6
0.66
160
662
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
37
54
6.94
24.20
2.8
2.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
44
77
5.80
24.15
1.2
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
248
1253
2.08
23.91
1.9
1.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
66
165
4.08
23.82
1.9
1.5
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
31
38
8.25
23.52
2.1
2.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
349
2014
1.85
22.79
4.7
3.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
280
1527
1.94
21.72
4.6
3.8
%
1.3
0.7
3.16
144
334
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1836
20457
0.64
21.60
4.6
5.3
mmol/l
2.7
2.7
0.04
1618
18633
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
615
4211
1.61
21.39
1.9
1.8
mg/l
2.1
1.2
3.58
499
3216
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
68
188
3.69
21.35
1.7
1.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1791
20007
0.65
20.42
4.2
4.7
mmol/l
4.5
4.5
0.45
1592
18329
(3027945) Reticulocytes/100 erythrocytes in Blood
398
2466
1.73
20.28
2.2
2.2
%
1.8
1.8
0.28
361
2141
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1772
19832
0.65
20.28
4.1
4.6
mmol/l
1.4
1.4
4.10
1560
18040
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
229
1202
1.99
19.81
1.5
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
381
2358
1.72
19.44
1.6
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
75
236
3.24
19.32
1.7
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
80
264
3.10
19.05
1.4
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
825
6165
1.50
18.93
3.4
3.2
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
195
992
2.05
18.38
5.4
3.9
mmol/l
24.4
24.2
0.36
183
880
(40768800) Prostate Pathology biopsy report
52
135
3.91
17.88
1.1
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
259
1473
1.84
17.55
4.6
3.9
%
0.2
0.1
2.14
134
312
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
156
742
2.17
17.53
2.5
2.3
ug/l
446.1
753.8
0.52
145
696
(3026493) Urate [Moles/volume] in Serum or Plasma
730
5408
1.49
17.14
3.8
2.4
umol/l
2912.2
6419.0
1.97
653
4581
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
37
76
4.93
17.10
3.4
2.1
%
39.9
44.5
—
9
34
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
20
21
9.59
17.00
3.1
1.5
ng/l
68.7
86.8
—
9
11
(40765096) Chromosome analysis panel by Banding
22
27
8.21
16.64
1.2
1.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
45
111
4.11
16.60
1.8
1.5
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
39
86
4.59
16.58
2.2
1.6
e9/l
0.2
0.2
0.34
31
76
(3042631) Mycobacterium sp identified in Specimen
71
238
3.04
16.49
2.2
3.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
127
573
2.28
16.24
4.0
3.6
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
22
28
7.92
16.16
1.6
1.9
e6/l
668.3
296.9
0.28
12
16
(3000494) Fungus identified in Specimen by Culture
352
2248
1.66
15.78
1.6
1.4
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
39
91
4.34
15.47
2.2
1.6
e6/l
524.1
454.1
0.35
30
77
(3023520) Reticulocytes [#/volume] in Blood
301
1854
1.71
15.46
2.2
2.2
e9/l
68.8
68.7
0.01
204
1411
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1730
19176
0.70
15.15
3.8
4.2
mmol/l
1.3
1.3
1.44
1504
17296
(3017354) Segmented neutrophils/100 leukocytes in Blood
54
162
3.38
15.07
3.8
2.9
%
56.2
58.8
0.31
38
104
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1719
19069
0.70
15.05
5.8
6.3
mmol/mol
40.3
40.5
0.39
1547
17505
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
20
25
8.06
14.89
1.3
1.4
%
17.1
5.4
1.07
13
11
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
19
6
31.89
14.80
1.1
1.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
78
293
2.71
14.76
1.6
1.4
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
18
20
9.06
14.66
1.2
1.2
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
314
1995
1.65
14.30
4.6
3.6
kpa
5.8
5.8
0.63
305
1928
(3002179) Metamyelocytes/100 leukocytes in Blood
239
1414
1.76
14.14
4.5
3.7
%
1.0
0.5
1.93
102
253
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
124
587
2.17
14.13
1.2
1.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
312
1988
1.65
14.04
4.6
3.6
mmol/l
1.8
2.0
0.29
264
1601
(3009214) Lutropin [Units/volume] in Serum or Plasma
85
344
2.52
13.87
1.8
1.4
u/l
16.3
9.0
2.59
71
272
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
34
79
4.35
13.58
2.6
1.2
ug/l
34.3
3.4
0.48
18
66
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
57
189
3.06
13.54
1.1
1.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1589
13885
1.38
13.45
5.5
4.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
47
139
3.43
13.44
1.9
1.5
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
13
10
13.06
13.37
2.1
1.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
221
1300
1.77
13.33
3.1
2.2
g/l
9.5
10.7
3.70
204
1183
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
576
4249
1.46
13.29
3.8
3.9
ng/l
155.8
445.7
4.85
477
3479
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
62
224
2.81
12.67
1.6
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
97
435
2.28
12.64
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
97
435
2.28
12.64
1.5
1.3
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
19
28
6.83
12.30
8.2
1.1
u/l
97.8
38.1
—
6
10
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
62
228
2.76
12.27
1.7
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
230
1409
1.69
11.99
4.6
3.9
%
0.1
0.4
0.41
112
276
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
25
50
5.04
11.94
2.6
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
25
50
5.04
11.94
2.6
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
25
50
5.04
11.94
2.6
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
37
101
3.70
11.94
4.8
3.9
—
—
—
0
0
(3019060) Gas panel - Arterial blood
229
1404
1.69
11.90
4.5
4.8
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2150
19963
1.48
11.71
28.7
13.4
mg/l
35.3
23.9
36.27
1968
15588
(3036481) Cortisol [Moles/volume] in Serum or Plasma
266
1706
1.62
11.61
3.3
1.8
nmol/l
404.1
361.3
2.61
254
1527
(3012501) Base excess in Blood by calculation
93
426
2.23
11.54
4.3
4.6
mmol/l
2.7
2.8
0.11
75
281
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
66
259
2.59
11.52
1.6
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
34
91
3.77
11.29
1.9
1.4
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
27
61
4.46
11.19
5.6
1.1
u/ml
11.2
92.8
—
8
18
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
21
38
5.56
11.17
1.2
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
34
92
3.73
11.12
1.9
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
70
288
2.47
11.09
2.1
2.1
u/l
103.4
2144.9
1.83
19
121
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
48
163
2.98
11.00
2.0
1.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
37
107
3.49
10.99
1.8
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
93
438
2.17
10.80
2.9
3.9
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
249
1601
1.62
10.74
7.1
2.9
mmol/l
1.2
1.2
0.07
227
1344
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
76
330
2.34
10.71
4.4
3.4
%
60.8
57.7
1.18
76
330
(40760892) CBC W Ordered Manual Differential panel - Blood
531
4014
1.41
10.42
5.6
4.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
28
69
4.09
10.41
2.4
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
28
69
4.09
10.41
2.4
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
28
69
4.09
10.41
2.4
1.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
28
69
4.09
10.41
2.4
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
50
180
2.81
10.34
2.0
1.4
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
40
128
3.16
10.16
1.3
1.5
nmol/l
0.4
0.3
0.05
27
103
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
214
1344
1.65
10.14
4.0
4.2
mmol/l
2.6
1.8
2.01
177
963
(3030905) Polymorphonuclear cells [#/volume] in Blood
73
321
2.31
10.02
4.0
3.2
e9/l
4.3
4.2
0.21
73
321
(3028026) IgM [Mass/volume] in Serum or Plasma
174
1044
1.72
9.80
2.0
1.4
g/l
1.0
1.2
1.32
156
948
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
146
835
1.79
9.71
2.5
1.7
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
14
19
7.40
9.70
1.6
1.1
—
—
—
0
0
(3010421) pH of Blood
100
506
2.02
9.65
4.2
4.3
ph
7.4
7.4
1.11
92
418
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
819
6702
1.33
9.57
3.2
3.1
ng/l
1701.3
1547.3
0.45
733
5737
(3009343) pH of Capillary blood
217
1389
1.61
9.53
4.1
4.3
ph
7.4
7.4
0.26
24
167
(40761995) Spermatozoa Progressive [#/volume] in Semen
15
23
6.55
9.35
2.1
3.2
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
15
23
6.55
9.35
4.1
6.4
—
—
—
0
0
(3044889) 12 lead EKG panel
1593
14289
1.30
9.30
4.3
4.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1782
16240
1.32
9.21
35.5
16.0
%
14.3
13.7
51.64
1756
15785
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
663
5285
1.34
9.21
2.1
2.3
mg/l
3.0
2.9
0.49
564
4454
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
217
1409
1.59
8.98
4.1
4.3
kpa
5.2
5.2
0.51
208
1295
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1851
19872
0.75
8.96
4.8
4.9
mmol/l
6.1
6.0
0.39
1642
17894
(3008152) Bicarbonate [Moles/volume] in Arterial blood
207
1347
1.58
8.50
7.1
6.8
mmol/l
25.0
24.6
1.27
197
1247
(3022313) Gas panel - Capillary blood
164
1009
1.67
8.44
4.4
4.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
90
464
1.97
8.29
1.2
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
233
1568
1.53
8.25
5.5
4.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
38
137
2.80
7.91
2.1
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
38
137
2.80
7.91
2.1
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
38
137
2.80
7.91
2.1
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
47
194
2.45
7.50
4.4
3.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
512
6363
0.76
7.25
2.9
3.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
81
426
1.93
7.09
2.6
2.4
%
15.6
16.4
0.57
35
230
(44790048)
46
194
2.40
7.03
1.4
1.5
—
—
—
0
0
(44806118)
46
194
2.40
7.03
1.4
1.5
—
—
—
0
0
(44790049)
46
194
2.40
7.03
1.4
1.5
—
—
—
0
0
(44790047)
46
194
2.40
7.03
1.4
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
84
458
1.86
6.62
1.5
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
29
100
2.92
6.58
1.8
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
49
222
2.23
6.39
1.7
1.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
82
450
1.85
6.34
1.8
1.3
iu/l
34.2
29.7
0.45
67
385
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
147
949
1.58
6.29
1.4
1.6
g/l
2.0
1.5
4.85
128
811
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
451
5608
0.76
6.27
1.6
1.6
mmol/l
1.3
1.3
0.00
370
4656
(3032352) Blasts [#/volume] in Cerebral spinal fluid
9
5
18.06
6.26
1.4
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
49
226
2.19
6.14
1.7
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
39
163
2.41
6.12
1.2
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
125
782
1.63
6.10
1.2
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
48
221
2.19
6.04
1.7
1.3
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
234
1679
1.43
6.04
4.4
3.1
kpa
4.6
4.6
0.15
224
1619
(3037692) Legionella sp identified in Specimen by Organism specific culture
20
58
3.47
6.01
1.5
1.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
17
44
3.88
5.98
1.8
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
48
223
2.17
5.92
1.7
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
124
781
1.62
5.90
2.3
1.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
49
231
2.14
5.83
1.7
1.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
19
55
3.47
5.73
2.2
2.7
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
16
41
3.92
5.71
1.4
1.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
153
1024
1.53
5.61
4.1
3.0
pmol/l
4.4
4.5
0.56
139
882
(3024522) Salmonella sp identified in Specimen by Organism specific culture
48
229
2.12
5.56
1.7
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1888
17746
1.24
5.44
31.1
14.8
%
37.7
39.5
14.09
1328
11765
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
23
78
2.97
5.41
1.0
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
106
660
1.63
5.31
4.9
2.8
g/l
0.3
0.3
0.40
74
231
(3014891) Appearance of Pleural fluid
12
26
4.63
5.26
2.6
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
74
419
1.79
5.24
1.5
1.3
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
5
0
+∞
5.21
1.2
0.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
16
44
3.65
5.20
1.1
2.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
58
308
1.90
5.03
1.7
1.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1099
9845
1.20
4.98
6.2
5.0
estimate
0.0
0.0
0.50
224
1730
(3047181) Lactate [Moles/volume] in Blood
102
641
1.62
4.95
6.4
6.4
mmol/l
1.3
1.3
0.07
93
562
(3020682) Albumin/Creatinine [Ratio] in Urine
611
7155
0.81
4.93
3.8
4.0
mg/mmol
8.6
10.6
0.33
375
4505
(3025941) Bacteria identified in Stool by Culture
147
1007
1.49
4.86
1.3
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
42
202
2.10
4.81
3.7
3.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
146
2066
0.69
4.59
1.7
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
1105
9960
1.19
4.55
4.6
3.7
estimate
0.0
0.0
1.08
219
1665
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
263
2023
1.33
4.48
2.3
3.1
ng/l
191.1
221.0
0.73
233
1857
(3013707) Erythrocyte sedimentation rate by Westergren method
1613
15052
1.19
4.41
4.1
4.2
mm/h
18.0
12.5
18.81
1471
13843
(40768797) Stomach Pathology biopsy report
340
2719
1.29
4.37
1.3
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
15
45
3.35
4.32
1.0
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
104
680
1.55
4.31
2.7
1.8
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
26
107
2.44
4.30
1.4
2.2
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
36
172
2.11
4.23
1.1
1.1
u/l
60.1
56.2
0.19
25
114
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1965
18705
1.22
4.22
27.6
12.3
ml/min/173m2
79.0
76.7
4.76
1772
15005
(3011397) Hemoglobin [Presence] in Urine by Test strip
569
4846
1.22
4.22
4.4
3.7
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
89
566
1.59
4.17
3.7
1.4
g/l
0.0
0.0
0.00
82
523
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
23
91
2.54
4.13
9.6
6.3
u/ml
2238.4
62.7
—
8
23
(3043409) Potassium [Moles/volume] in Arterial blood
99
647
1.55
4.13
3.9
4.0
mmol/l
3.8
3.9
0.76
89
606
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
210
1586
1.35
4.06
5.2
2.4
ml/min/173m2
59.9
64.1
0.78
85
644
(3022217) INR in Platelet poor plasma by Coagulation assay
375
3069
1.26
3.99
21.9
28.3
inr
1.4
1.4
0.00
39
421
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
11
28
3.94
3.97
2.3
1.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
910
8140
1.18
3.93
2.7
2.8
ug/l
267.3
129.6
5.46
850
7439
(3043410) Blood group antigens tested for on Red Blood Cells
15
48
3.14
3.93
3.8
1.3
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
89
576
1.56
3.89
3.7
1.4
g/l
0.0
0.0
0.76
82
524
(3019550) Sodium [Moles/volume] in Serum or Plasma
2178
21005
1.25
3.85
31.1
16.2
mmol/l
139.0
139.7
26.94
2135
20393
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
49
272
1.82
3.79
1.6
1.4
u/ml
98.6
105.4
—
10
51
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
93
612
1.54
3.79
3.6
1.4
g/l
0.4
0.0
0.86
86
559
(3012516) Albumin [Mass/volume] in Urine
589
6769
0.83
3.75
3.1
3.3
mg/l
198.6
243.7
0.17
371
4279
(3020393) Adenovirus Ag [Presence] in Stool
10
25
4.01
3.70
1.1
2.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
13
40
3.26
3.62
3.2
1.6
—
—
—
0
0
(3019225) pH of Specimen
260
2066
1.29
3.53
5.4
3.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
245
1934
1.30
3.50
1.4
1.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
118
830
1.44
3.50
3.2
1.4
g/l
3.9
3.8
0.15
88
590
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
35
179
1.97
3.48
2.7
2.7
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
118
831
1.44
3.48
3.2
1.4
g/l
7.7
7.4
0.70
90
610
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
118
831
1.44
3.48
3.2
1.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
214
1661
1.31
3.46
3.6
3.7
ng/l
85.6
91.4
0.50
188
1397
(3047189) Immunofixation for 24 hour Urine
19
75
2.54
3.46
2.5
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
50
288
1.75
3.45
1.3
1.2
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
97
661
1.49
3.39
3.5
1.4
g/l
36.9
37.6
0.57
86
551
(3023103) Potassium [Moles/volume] in Serum or Plasma
2178
21066
1.23
3.37
31.4
16.3
mmol/l
4.0
4.0
2.80
2134
20416
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
7
10
7.01
3.36
2.3
1.6
pmol/l
36.5
76.3
—
7
10
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
36
189
1.92
3.34
1.6
1.6
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
135
983
1.39
3.31
3.5
2.6
%
0.6
0.7
0.21
126
939
(3023419) Bacteria identified in Sputum by Culture
48
277
1.75
3.31
2.0
2.7
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
111
781
1.44
3.30
3.3
1.4
g/l
10.2
10.4
0.12
97
646
(3003327) Ova and parasites identified in Stool by Light microscopy
84
559
1.52
3.29
1.7
1.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
260
3211
0.79
3.29
1.2
1.2
u/ml
17.2
14.0
0.25
79
1201
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
100
691
1.47
3.27
3.7
1.5
g/l
1.8
0.5
1.19
89
589
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
27
129
2.10
3.24
2.9
2.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
191
1474
1.32
3.23
3.5
1.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1071
9820
1.16
3.21
4.6
3.7
estimate
0.0
0.0
0.00
229
1710
(3037756) Immunofixation for Serum or Plasma
62
389
1.61
3.15
2.4
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
63
397
1.60
3.14
2.6
2.8
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
109
775
1.42
3.08
3.4
1.4
g/l
3.5
3.1
2.59
88
602
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
11
34
3.24
3.06
1.1
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
73
481
1.53
3.02
1.8
2.0
g/l
124.9
131.0
0.84
47
358
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
41
233
1.77
3.00
1.5
1.3
nmol/l
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1315
12275
1.15
2.98
3.9
3.0
u/l
59.0
47.4
3.07
1226
11200
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
72
477
1.52
2.92
1.2
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
42
243
1.74
2.91
1.5
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
24
115
2.10
2.88
1.4
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
19
84
2.27
2.77
1.5
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
19
84
2.27
2.77
1.5
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
24
117
2.06
2.77
1.4
1.3
—
—
—
0
0
(3020891) Body temperature
118
869
1.38
2.76
4.5
4.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
25
124
2.03
2.76
1.6
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
87
1222
0.70
2.72
1.4
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
29
153
1.91
2.70
1.1
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
33
183
1.81
2.65
3.6
1.2
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
171
1341
1.29
2.62
3.9
3.2
g/l
120.5
130.4
7.38
164
1296
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
14
55
2.55
2.61
1.6
1.6
iu/ml
—
1679021.4
—
0
7
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
0
70
0.00
2.58
0.0
2.5
—
148.3
—
0
61
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
80
557
1.45
2.58
1.1
1.1
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
5
7
7.15
2.55
2.0
1.0
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
167
1316
1.29
2.48
2.9
3.2
e9/l
4.5
4.1
1.04
131
952
(44816559) Phosphatidylethanol [Mass/volume] in Blood
17
352
0.48
2.46
1.1
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1784
18539
0.88
2.45
4.9
4.6
mu/l
2.0
2.0
0.38
1600
16712
(3015235) Bicarbonate [Moles/volume] in Capillary blood
80
565
1.43
2.42
2.7
3.5
mmol/l
24.9
25.1
0.10
71
496
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
27
145
1.87
2.41
1.7
1.2
—
—
—
0
0
(3019977) pH of Arterial blood
22
110
2.01
2.40
2.0
2.3
ph
7.4
7.4
—
5
43
(3028433) Virus identified in Specimen by Culture
15
64
2.35
2.38
1.1
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
43
675
0.63
2.38
1.3
1.7
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
158
1985
0.78
2.34
1.4
1.8
%
1.5
1.5
0.03
138
1694
(3014765) Yersinia sp identified in Stool by Organism specific culture
79
561
1.42
2.33
1.1
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
100
1334
0.74
2.31
1.7
1.7
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
26
141
1.85
2.27
2.7
2.6
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
6
13
4.62
2.27
1.8
2.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
638
7042
0.87
2.26
3.0
3.2
mmol/l
7.3
7.4
0.18
521
5883
(3024928) Oxygen saturation in Venous blood
64
441
1.46
2.22
5.2
3.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
79
567
1.41
2.21
1.1
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
105
792
1.34
2.17
1.6
1.8
u/l
37.2
38.5
0.25
92
673
(3000570) Elastase.pancreatic [Mass/mass] in Stool
74
529
1.41
2.13
1.3
1.4
ug/g
238.9
288.1
1.47
50
315
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
287
3351
0.84
2.12
1.2
1.3
iu/ml
32.6
38.3
0.30
80
1026
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
8
25
3.21
2.09
3.3
2.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
28
161
1.75
2.06
7.2
2.4
%
10.5
10.9
0.20
28
161
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
7
20
3.51
2.05
1.0
1.4
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
6
15
4.01
2.04
1.2
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
36
563
0.63
2.00
1.0
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
43
280
1.54
1.98
1.1
1.0
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
144
1152
1.26
1.96
2.6
2.2
nmol/l
11.6
14.4
4.57
128
997
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
5
11
4.55
1.94
1.0
1.1
ng/l
729.4
3474.6
—
5
5
(40761511) CBC panel - Blood by Automated count
2121
20685
1.15
1.90
23.9
13.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
58
406
1.44
1.90
2.7
2.6
umol/l
33.1
33.4
0.04
51
345
(4034850)
52
744
0.69
1.89
10.6
9.9
—
—
—
0
0
(3000012) Reticulocyte production index
21
114
1.85
1.87
1.5
1.5
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
20
107
1.88
1.86
1.8
1.4
u/l
1.5
7.3
1.68
14
42
(3016018) Differential panel - Cerebral spinal fluid
32
198
1.62
1.83
1.1
1.4
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
12
4.17
1.82
1.4
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
889
8286
1.11
1.79
4.1
3.9
ng/l
34.6
65.9
2.31
719
6009
(3044290) Cell count panel - Cerebral spinal fluid
55
386
1.43
1.79
1.1
1.3
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
11
47
2.35
1.77
1.6
1.9
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
66
891
0.73
1.72
1.5
1.4
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
7
24
2.92
1.72
2.3
2.4
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
7
24
2.92
1.72
1.4
1.5
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
68
500
1.37
1.71
1.2
1.2
titre
57.1
80.8
—
7
39
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
37
242
1.54
1.70
1.1
1.2
u/ml
2.4
6.7
2.19
14
105
(3047007) Chlamydophila sp Ab [Presence] in Serum
36
234
1.55
1.70
1.1
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
572
5217
1.12
1.69
1.5
1.5
nmol/l
19.9
20.4
0.31
507
4360
(3003181) Sodium [Moles/volume] in Urine
53
375
1.42
1.67
1.3
1.4
mmol/l
71.1
63.4
0.52
35
296
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
11
49
2.25
1.63
1.2
1.0
%
66.8
84.0
—
5
23
(3024980) IgG subclass 4 [Mass/volume] in Serum
42
286
1.48
1.62
1.6
1.7
g/l
0.8
0.9
0.30
34
221
(3039443) Prostate specific Ag panel - Serum or Plasma
20
340
0.58
1.62
1.4
1.6
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
44
628
0.70
1.62
1.6
1.6
mg/l
4.6
4.3
0.05
27
441
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
366
4100
0.87
1.60
1.2
1.3
u/ml
0.9
2.0
2.95
61
1055
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
6
20
3.00
1.58
5.2
1.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
12
57
2.11
1.55
2.3
2.7
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
12
57
2.11
1.55
2.3
2.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
88
1120
0.78
1.53
1.9
1.8
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
8
33
2.43
1.53
1.0
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
562
6117
0.90
1.53
4.4
3.8
%
22.9
24.2
0.94
278
2999
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
41
586
0.69
1.53
2.3
2.3
ug/min
108.8
99.2
0.09
26
358
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
99
1241
0.79
1.53
1.9
1.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
36
241
1.50
1.52
1.1
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
19
108
1.76
1.50
1.2
1.3
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
19
108
1.76
1.50
1.8
1.8
—
11.8
—
0
6
(3005322) IgE [Units/volume] in Serum or Plasma
91
1148
0.79
1.49
1.3
1.3
u/ml
1466.2
251.1
0.57
85
1053
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
236
2710
0.86
1.47
4.3
4.8
%
31.7
33.2
1.28
159
1770
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
41
286
1.44
1.43
1.1
1.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
17
95
1.79
1.43
2.5
4.8
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
9
40
2.25
1.40
1.0
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
28
182
1.54
1.37
1.2
1.5
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
34
231
1.48
1.36
1.1
1.1
%
128.1
113.2
1.06
29
210
(3050129) First trimester maternal screen panel - Serum or Plasma
12
222
0.54
1.35
1.3
1.5
—
—
—
0
0
(4268621)
26
167
1.56
1.34
2.0
2.3
—
—
—
0
0
(3013512) EKG study
666
6200
1.10
1.34
4.4
4.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
6
24
2.50
1.30
2.3
2.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
14
76
1.85
1.29
2.1
2.3
u/ml
1002.6
1051.1
0.06
14
76
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
59
447
1.33
1.29
1.6
1.8
iu/l
4.7
4.7
0.00
20
148
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
60
457
1.32
1.27
1.3
1.3
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
81
643
1.27
1.26
6.0
1.5
mg/l
44.4
45.7
0.02
69
513
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1479
15294
0.92
1.26
4.2
3.8
pmol/l
14.8
14.9
0.68
1325
13719
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
18
107
1.69
1.25
1.2
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
18
107
1.69
1.25
1.2
1.0
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
57
432
1.33
1.25
1.1
1.3
e6/l
49.4
28.4
0.33
43
341
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
57
432
1.33
1.25
1.2
1.4
e6/l
709.4
1521.0
0.49
46
355
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
42
303
1.39
1.25
1.5
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2172
21339
1.12
1.25
19.1
9.2
u/l
25.6
25.6
0.03
2111
20357
(3034860) Kappa light chains.free [Mass/volume] in Serum
81
645
1.26
1.24
6.0
1.5
mg/l
40.8
47.4
0.26
69
516
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
44
595
0.73
1.23
1.5
1.7
—
—
—
0
0
(3034426) Prothrombin time (PT)
11
56
1.97
1.22
1.2
1.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
24
156
1.54
1.20
1.1
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
6
26
2.31
1.18
1.2
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
6
26
2.31
1.18
1.7
1.6
—
—
—
0
0
(4306422)
34
239
1.43
1.18
1.2
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
416
4536
0.90
1.18
4.6
4.1
kg/l
1.0
1.0
0.92
61
697
(3006922) Hepatitis E virus Ab [Presence] in Serum
18
110
1.64
1.15
1.2
1.1
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
78
625
1.26
1.15
5.9
1.5
ratio
1.3
2.5
—
6
55
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
15
87
1.73
1.15
1.2
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
15
87
1.73
1.15
1.2
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
61
474
1.29
1.14
6.1
1.5
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
72
573
1.26
1.13
1.6
1.6
iu/ml
0.5
5.0
0.45
22
125
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
719
6767
1.09
1.13
2.6
2.1
u/l
173.1
213.4
1.26
685
6309
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
114
0.44
1.12
1.4
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
57
441
1.30
1.11
1.4
1.3
—
—
—
0
0
(4062490)
27
184
1.47
1.10
1.6
1.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
235
2089
1.14
1.10
2.4
2.4
ug/l
8.5
7.4
0.30
213
1808
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
34
243
1.40
1.09
1.1
1.1
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
5
21
2.38
1.09
6.2
1.6
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
5
21
2.38
1.09
1.0
1.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
35
252
1.39
1.08
1.1
1.4
pmol/l
708.6
296.2
0.61
30
190
(3023511) Choriogonadotropin [Units/volume] in Urine
22
144
1.53
1.08
1.3
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
201
1773
1.15
1.06
3.8
3.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
19
121
1.57
1.05
1.4
1.7
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
46
350
1.32
1.02
1.2
1.2
u/l
72.2
20.0
0.78
35
300
(3024471) HLA-A [Type]
9
47
1.92
1.02
1.0
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
17
263
0.64
1.02
1.1
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
572
5360
1.09
0.99
5.2
4.0
estimate
0.0
0.0
0.88
212
1677
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
34
248
1.38
0.99
1.1
1.2
u/ml
1.6
2.9
—
7
74
(3004716) Salmonella sp identified in Stool by Organism specific culture
101
848
1.20
0.99
1.3
1.3
—
—
—
0
0
(3048879) Bone marrow aspiration report
9
49
1.84
0.98
3.0
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
38
283
1.35
0.98
1.3
1.3
u/ml
318.6
247.5
0.69
23
168
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
9
160
0.56
0.98
1.1
1.7
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
0
29
0.00
0.97
0.0
1.2
—
5.7
—
0
12
(4146454)
18
272
0.66
0.97
1.8
2.7
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
16
100
1.60
0.96
1.2
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
25
353
0.71
0.96
1.3
1.5
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
23
157
1.47
0.96
3.1
1.7
—
1.7
—
0
12
(3024139) IgG subclass 3 [Mass/volume] in Serum
26
182
1.43
0.96
1.6
1.4
g/l
0.5
0.4
0.64
19
130
(3027135) IgG subclass 1 [Mass/volume] in Serum
26
182
1.43
0.96
1.6
1.4
g/l
7.5
6.8
0.32
20
131
(3028192) IgG subclass 2 [Mass/volume] in Serum
26
182
1.43
0.96
1.6
1.4
g/l
3.8
2.9
0.68
20
128
(3033705) Calcium.ionized [Moles/volume] in Venous blood
36
268
1.35
0.94
2.4
2.1
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
6
116
0.52
0.94
1.0
1.1
mg/l
265.8
253.8
—
6
105
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
27
2.23
0.93
1.2
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
44
339
1.30
0.92
3.9
2.9
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
23
326
0.70
0.91
1.2
1.1
iu/ml
1.0
117.5
—
6
66
(3038177) Helicobacter pylori Ab [Presence] in Serum
35
262
1.34
0.89
1.5
1.3
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
6
29
2.07
0.89
1.0
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
60
485
1.24
0.87
2.6
2.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
379
3514
1.09
0.85
1.7
1.3
g/l
2.5
2.6
0.18
235
2011
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
6
31
1.94
0.84
1.0
1.0
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1701
16637
1.07
0.84
38.1
17.6
g/l
329.6
332.3
26.60
1681
16495
(3036071) Salmonella sp Ab [Titer] in Serum
10
57
1.76
0.83
1.0
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
113
0.53
0.83
1.0
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
8
46
1.74
0.82
1.0
1.0
—
—
—
0
0
(3000492) Spirometry study
192
1724
1.12
0.81
1.7
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
26
189
1.38
0.81
1.5
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
39
303
1.29
0.79
1.1
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
33
1.82
0.79
1.2
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
16
106
1.51
0.79
1.1
1.7
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
14
211
0.66
0.78
2.8
3.1
mg/l
12.7
24.0
—
7
164
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
40
507
0.79
0.78
1.1
1.2
u/ml
2.3
6.4
—
6
81
(1002224) Polysomnography panel
54
659
0.82
0.76
1.1
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
6
34
1.77
0.76
1.2
1.2
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
5
24
2.09
0.74
1.2
1.0
u/ml
55.8
43.1
—
5
24
(3048689) Calprotectin [Mass/mass] in Stool
196
2162
0.90
0.74
2.2
2.2
ug/g
149.1
148.2
0.01
162
1686
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
17
116
1.47
0.74
1.2
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
5
25
2.00
0.72
1.0
1.2
umol/24h
1.9
1.7
—
5
25
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
56
461
1.22
0.72
1.2
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
7
39
1.80
0.72
1.0
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
31
237
1.31
0.72
1.2
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
17
117
1.46
0.71
1.2
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
18
126
1.43
0.70
2.6
3.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
45
553
0.81
0.69
1.6
1.6
e6/l
18954.0
13241.6
0.41
33
404
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
253
2331
1.09
0.68
1.4
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
52
628
0.82
0.68
1.8
1.8
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
7
42
1.67
0.68
1.0
1.2
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
7
42
1.67
0.68
1.9
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
50
606
0.82
0.68
1.5
1.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
15
102
1.47
0.67
1.1
1.0
—
—
—
0
0
(4027681)
5
92
0.54
0.67
1.2
1.2
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
5
28
1.79
0.66
1.8
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
414
4390
0.93
0.66
1.8
1.8
nmol/l
1155.0
1158.7
0.02
294
3267
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
20
145
1.38
0.65
1.6
1.6
umol/l
11.7
13.3
0.44
20
132
(37021550) Renin [Units/volume] in Plasma --upright
7
44
1.59
0.65
1.6
1.3
mu/l
96.9
69.6
—
7
28
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
26
198
1.32
0.64
1.0
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
8
49
1.63
0.62
2.3
1.3
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
12
176
0.68
0.62
1.1
1.1
—
63.0
—
0
8
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
30
1.67
0.61
1.8
1.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
14
96
1.46
0.61
1.7
1.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
16
113
1.42
0.61
2.2
2.5
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
8
51
1.57
0.60
1.8
1.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
453
4772
0.94
0.60
1.7
1.7
pmol/l
69837400.6
31309915.5
0.44
368
3887
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
111
1245
0.89
0.59
1.3
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
38
308
1.24
0.59
1.1
1.2
—
—
—
0
0
(4094501)
46
552
0.83
0.59
1.1
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
6
35
1.72
0.57
1.5
1.3
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
12
173
0.69
0.57
1.1
1.1
—
87.8
—
0
9
(3004616) Nuclear Ab [Presence] in Serum
19
252
0.75
0.56
1.1
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
10
65
1.54
0.55
1.0
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
13
90
1.45
0.55
1.2
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
15
107
1.40
0.55
1.6
1.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
55
468
1.18
0.54
3.7
3.5
mg/l
40.2
27.2
1.17
37
299
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
36
438
0.82
0.54
1.3
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
33
402
0.82
0.51
1.9
1.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
21
269
0.78
0.50
1.0
1.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
101
1.39
0.49
1.1
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
7
45
1.56
0.49
1.4
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
23
181
1.27
0.48
1.3
1.2
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
12
166
0.72
0.47
1.1
1.4
—
223.2
—
0
19
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
40
473
0.84
0.47
1.4
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
64
561
1.14
0.46
3.7
4.2
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
5
83
0.60
0.45
1.2
1.6
ug/l
3.3
9.9
—
5
67
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
20
156
1.28
0.45
1.1
1.2
titre
314.0
136.5
—
5
26
(3023410) Appearance of Cerebral spinal fluid
24
192
1.25
0.45
1.2
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
41
349
1.18
0.43
1.7
1.3
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
32
381
0.84
0.42
1.1
1.2
u/ml
26.8
49.4
—
5
39
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
0.0
—
0
7
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3011841) English Walnut IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
2.6
—
0
10
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
0.0
—
0
8
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.0
—
4.0
—
0
10
(3032868) Hemoglobin electrophoresis panel in Blood
0
17
0.00
0.40
0.0
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
121
1113
1.09
0.40
3.5
3.4
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
10
137
0.73
0.39
1.3
1.7
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
5
36
1.39
0.38
1.2
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
57
505
1.13
0.37
1.1
1.1
u/ml
3.4
8.1
—
8
49
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
(44806420)
9
71
1.27
0.36
1.9
2.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
111
1025
1.09
0.35
1.7
1.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
42
367
1.15
0.34
1.4
1.2
miu/ml
270.3
197.6
0.55
19
161
(3045414) Leukocytes [Presence] in Urine
99
911
1.09
0.34
2.1
1.9
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
141
1508
0.93
0.34
1.2
1.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
26
218
1.19
0.34
1.1
1.0
u/ml
2.7
2.2
0.15
13
86
(3037522) Nuclear Ab [Titer] in Serum
273
2606
1.05
0.34
1.3
1.3
titre
567.2
577.4
0.03
50
570
(3008295) Osmolality of Serum or Plasma
24
200
1.20
0.33
1.1
1.4
mosm/kgh2o
279.4
278.1
0.11
16
150
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
16
199
0.80
0.33
1.2
1.1
—
1.7
—
0
5
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
6
47
1.28
0.32
1.2
1.1
pmol/l
404.5
242.1
—
6
29
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
411
4255
0.96
0.32
3.1
2.7
ug/l
0.8
0.7
0.26
297
2910
(3022621) pH of Urine by Test strip
130
1390
0.93
0.32
3.2
3.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
41
465
0.88
0.32
1.9
1.7
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
12
93
1.29
0.30
1.2
1.2
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
12
93
1.29
0.30
1.0
1.1
—
4.2
—
0
5
(3003740) Influenza virus B Ag [Presence] in Specimen
25
213
1.18
0.29
1.0
1.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
8
107
0.75
0.29
1.5
1.3
mmol/l
6.0
6.1
—
8
102
(3041096) Erythrocytes [Presence] in Urine by Automated
525
5108
1.03
0.28
4.5
3.4
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
23
270
0.85
0.28
1.6
1.4
%
68.5
63.0
0.26
13
169
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
892
9088
0.97
0.28
1.9
2.0
pmol/l
91.1
94.3
1.19
499
4606
(4010399)
157
1486
1.06
0.28
1.3
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
17
205
0.83
0.28
1.4
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
104
1113
0.93
0.27
1.1
1.2
iu/ml
76.2
136.5
1.26
27
421
(3027456) Digoxin [Moles/volume] in Serum or Plasma
56
508
1.10
0.27
3.1
3.1
nmol/l
0.9
0.8
0.33
46
380
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
8
64
1.25
0.27
1.1
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
8
64
1.25
0.27
1.0
1.1
miu/ml
1917.5
1706.7
—
8
64
(3017704) Immunofixation for Urine
9
121
0.74
0.27
3.6
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
36
406
0.89
0.27
2.1
1.8
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
25
215
1.16
0.26
1.0
1.1
—
—
—
0
0
(44813793)
14
113
1.24
0.26
1.1
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
32
363
0.88
0.26
1.4
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
10
77
1.30
0.26
1.1
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
273
2629
1.04
0.26
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
16
192
0.83
0.25
1.2
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
16
192
0.83
0.25
1.2
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
24
277
0.87
0.25
3.1
2.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
14
114
1.23
0.25
1.1
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
36
403
0.89
0.25
1.9
1.8
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
16
191
0.84
0.24
1.2
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
16
191
0.84
0.24
1.2
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
36
402
0.89
0.24
1.9
1.8
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
18
152
1.19
0.23
1.0
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
13
158
0.82
0.23
1.2
1.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
13
158
0.82
0.23
1.2
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
12
147
0.82
0.23
1.2
1.5
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
21
243
0.86
0.23
1.2
1.3
mmol/l
8.2
7.8
0.13
15
170
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
106
1.23
0.23
1.1
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
269
2783
0.96
0.22
10.7
6.9
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
19
163
1.17
0.21
1.9
1.8
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016031) Almond IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
2.5
—
0
6
(3006653) Thiamine [Moles/volume] in Blood
8
101
0.79
0.21
1.0
1.3
nmol/l
124.8
144.9
—
8
101
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
43
1.16
0.21
1.0
1.5
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
8.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
24
211
1.14
0.20
1.0
1.1
—
—
—
0
0
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
2.6
—
0
6
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
34
376
0.90
0.20
1.9
1.8
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
6
48
1.25
0.20
6.3
4.3
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
51
1.18
0.19
1.0
1.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
52
1.15
0.19
1.2
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
11
132
0.83
0.18
10.8
12.8
—
—
—
0
0
(3024263) Appearance of Synovial fluid
15
129
1.16
0.17
1.6
1.6
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
8
70
1.14
0.16
2.1
2.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
14
162
0.86
0.16
1.3
1.5
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
44
473
0.93
0.16
2.5
1.8
nmol/l
36.9
41.1
0.86
44
449
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
9
79
1.14
0.15
1.0
1.2
—
—
—
0
0
(4024509)
23
207
1.11
0.15
1.8
1.6
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
19
213
0.89
0.15
1.7
2.0
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
9
82
1.10
0.15
2.3
2.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
2215
22216
0.98
0.13
41.9
19.6
e9/l
7.2
6.8
4.26
2144
21395
(3013139) Helicobacter pylori Ag [Presence] in Stool
128
1324
0.97
0.13
1.1
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
15
132
1.14
0.13
1.7
1.5
g/l
1.0
0.9
0.31
15
132
(3016750) Collection duration of Urine
15
132
1.14
0.13
1.7
2.0
min
505.7
496.4
—
10
98
(3026361) Erythrocytes [#/volume] in Blood
2215
22214
0.98
0.13
41.8
19.6
e12/l
4.3
4.5
66.86
2146
21387
(3007461) Platelets [#/volume] in Blood
2214
22204
0.98
0.13
41.9
19.6
e9/l
258.6
245.9
11.52
2149
21480
(3035941) MCH [Entitic mass]
2215
22213
0.98
0.13
41.7
19.5
pg
30.2
30.4
6.37
2178
21779
(3024731) MCV [Entitic volume]
2215
22211
0.98
0.12
41.7
19.5
fl
91.3
91.3
0.13
2178
21775
(3025018) Bordetella pertussis Ab [Titer] in Serum
12
104
1.15
0.12
1.3
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
66
692
0.95
0.12
1.7
1.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
14
157
0.89
0.11
1.2
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
14
156
0.90
0.10
1.2
1.4
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
2217
22219
0.98
0.09
42.1
19.7
g/l
126.6
135.7
114.84
2183
21779
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
20
184
1.09
0.09
2.0
2.1
u/field
1.6
1.9
0.19
12
73
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
828
8343
0.99
0.09
2.3
2.2
nmol/l
77.1
78.4
0.65
726
7273
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
15
165
0.91
0.08
1.1
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
55
573
0.96
0.08
2.0
1.8
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
58
1.03
0.08
1.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
61
0.82
0.08
1.2
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
5
60
0.83
0.08
1.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
5
60
0.83
0.08
1.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
5
60
0.83
0.08
1.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
5
60
0.83
0.08
1.0
1.1
—
—
—
0
0
(4015189)
5
62
0.81
0.08
1.8
2.3
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
7
64
1.09
0.08
1.0
1.5
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
7
66
1.06
0.08
7.4
8.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
751
7565
0.99
0.08
4.8
3.9
ug/l
2.7
2.6
0.08
649
6745
(3015183) Erythrocyte sedimentation rate
6
71
0.84
0.07
1.3
1.2
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
6
74
0.81
0.07
1.8
1.8
ug/l
9.7
124.9
—
6
67
(40768446) Kidney Pathology biopsy report
8
75
1.07
0.07
1.1
1.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
28
296
0.95
0.07
1.5
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1105
10998
1.01
0.07
2.7
2.6
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
11
99
1.11
0.06
2.2
3.8
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
12
109
1.10
0.06
1.1
1.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
130
1324
0.98
0.06
2.3
2.4
au/ml
10.4
26.3
—
7
51
(3006442) Creatine [Moles/volume] in Serum or Plasma
13
141
0.92
0.05
1.2
1.7
—
72.2
—
0
13
(3021788) Differential panel - Synovial fluid
39
403
0.97
0.04
1.6
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
34
328
1.04
0.04
1.4
1.5
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
121
1194
1.01
0.03
1.2
1.3
au/ml
18.6
46.7
—
5
50
(3028707) Methadone [Presence] in Urine by Screen method
17
179
0.95
0.03
2.6
2.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
10
108
0.93
0.03
1.1
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
30
309
0.97
0.02
2.7
1.8
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
11
103
1.07
0.02
1.5
1.3
u/l
812.5
348.1
0.51
11
94
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
15
143
1.05
0.01
1.2
1.2
u/ml
0.0
1.7
—
6
66
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
92
929
0.99
0.01
1.0
1.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
18
187
0.96
0.01
2.0
2.3
ml
532.1
621.3
0.67
11
123
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
28
287
0.98
0.01
1.0
1.1
u/ml
1.5
2.6
—
10
119
(3023430) Cat dander IgE Ab [Units/volume] in Serum
17
176
0.97
0.00
1.1
1.1
u/ml
0.8
4.5
—
6
80
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
19
196
0.97
0.00
1.8
1.4
%
32.7
27.3
0.26
12
125
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
14
145
0.97
0.00
1.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
14
145
0.97
0.00
1.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
14
145
0.97
0.00
1.0
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
19
191
0.99
0.00
1.1
1.1
u/ml
2.7
3.7
—
5
82
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
112
1125
1.00
0.00
2.4
2.5
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
24
244
0.98
0.00
1.0
1.1
u/ml
0.2
0.9
—
10
108
(4211845)
11
108
1.02
0.00
2.2
3.7
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
13
128
1.02
0.00
1.0
1.4
u/l
5.7
6.3
0.32
13
111
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
757
7571
1.00
0.00
4.8
3.9
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
14
143
0.98
0.00
1.0
1.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
25
253
0.99
0.00
1.0
1.1
u/ml
3.4
4.7
0.25
12
127
(3000093) Morphology [Interpretation] in Blood Narrative
19
193
0.98
0.00
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
14
143
0.98
0.00
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
14
143
0.98
0.00
1.0
1.2
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
15
147
1.02
0.00
1.1
1.3
mmol/l
8.5
12.0
—
6
46
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
8
0.00
0.00
0.0
4.5
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
8
0.00
0.00
0.0
4.5
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
50
1.00
0.00
2.6
1.5
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
2.7
—
0
5
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
6
63
0.95
0.00
1.2
1.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
25
250
1.00
0.00
2.7
2.3
mg/l
18.2
21.4
—
5
52
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
15.6
—
0
7
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
59
0.85
0.00
8.4
8.1
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
6
67
0.90
0.00
3.3
2.4
ug/l
2.8
1.7
—
6
59
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
64
0.94
0.00
1.0
1.1
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
8
86
0.93
0.00
1.0
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
12
120
1.00
0.00
1.7
1.8
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
6
63
0.95
0.00
1.0
1.2
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
2.4
—
2.8
—
0
5
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
72
0.97
0.00
1.0
1.0
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
10
100
1.00
0.00
1.0
1.0
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
6.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
61
0.98
0.00
1.2
1.2
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
250.4
—
0
5
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
6.4
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
53
0.94
0.00
1.0
1.1
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_MESTOTHEL_SOFTTISSUE_EXALLC – Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).